| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.905 | 0.001 | 0.946 | Glutamate decarboxylase inhibitor | 0.926 0.001 DBMET02102 0.921 0.001 DBMET03078 0.105 0.027 DBMET03079 0.161 0.011 DBMET00494 0.946 0.001 DB00129 | DB00129 | |
| 0.825 | 0.001 | 0.825 | Glutamate dehydrogenase inhibitor | 0.79 0.001 DBMET02102 0.777 0.001 DBMET03078 0.117 0.024 DBMET03079 0.151 0.016 DBMET00494 0.807 0.001 DB00129 | ||
| 0.793 | 0.003 | 0.819 | Superoxide dismutase inhibitor | 0.676 0.005 DBMET02102 0.431 0.022 DBMET03078 0.273 0.062 DBMET03079 0.5 0.013 DBMET00494 0.819 0.003 DB00129 | DB00129 | |
| 0.752 | 0.001 | 0.797 | Ornithine carbamoyltransferase inhibitor | 0.486 0.003 DBMET02102 0.14 0.01 DBMET03078 0.067 0.027 DBMET03079 0.091 0.018 DBMET00494 0.797 0.001 DB00129 | DB00129 | |
| 0.705 | 0.003 | 0.705 | Peroxidase inhibitor | 0.666 0.003 DBMET02102 0.447 0.015 DBMET03078 0.255 0.046 DBMET03079 0.191 0.062 DBMET00494 0.681 0.003 DB00129 | ||
| 0.668 | 0.004 | 0.668 | Interleukin agonist | 0.563 0.006 DBMET02102 0.341 0.032 DBMET03078 0.24 0.086 DBMET03079 0.426 0.015 DBMET00494 0.647 0.004 DB00129 | ||
| 0.653 | 0.008 | 0.653 | Interleukin antagonist | 0.472 0.022 DBMET02102 0.277 0.053 DBMET03078 0.568 0.014 DB00129 | ||
| 0.629 | 0.004 | 0.635 | Alpha-N-acetylglucosaminidase inhibitor | 0.635 0.004 DBMET02102 0.625 0.004 DBMET03078 0.395 0.009 DBMET03079 0.627 0.004 DBMET00494 0.52 0.005 DB00129 | DBMET02102 | |
| 0.604 | 0.007 | 0.604 | Angiogenesis stimulant | 0.486 0.013 DBMET02102 0.32 0.042 DBMET03078 0.278 0.058 DBMET00494 0.549 0.009 DB00129 | ||
| 0.6 | 0.003 | 0.844 | GABA C receptor agonist | 0.798 0.001 DBMET02102 0.758 0.002 DBMET03078 0.449 0.004 DBMET03079 0.717 0.002 DBMET00494 0.844 0.001 DB00129 | DB00129 | |
| 0.593 | 0.006 | 0.684 | Psychostimulant | 0.581 0.007 DBMET02102 0.529 0.009 DBMET03078 0.527 0.009 DBMET00494 0.684 0.004 DB00129 | DB00129 | |
| 0.589 | 0.012 | 0.684 | Immunomodulator | 0.684 0.006 DBMET02102 0.194 0.171 DBMET03079 0.313 0.075 DBMET00494 0.613 0.01 DB00129 | DBMET02102 | |
| 0.572 | 0.003 | 0.653 | Tyrosine 3 hydroxylase inhibitor | 0.653 0.003 DBMET02102 0.476 0.004 DBMET03078 0.286 0.041 DBMET03079 0.489 0.004 DBMET00494 0.617 0.003 DB00129 | DBMET02102 | |
| 0.562 | 0.002 | 0.562 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.539 0.002 DBMET02102 0.505 0.002 DBMET03078 0.177 0.02 DBMET03079 0.312 0.005 DBMET00494 0.439 0.003 DB00129 | ||
| 0.554 | 0.002 | 0.639 | Histidine decarboxylase inhibitor | 0.504 0.003 DBMET02102 0.284 0.007 DBMET03078 0.108 0.029 DBMET03079 0.149 0.02 DBMET00494 0.639 0.002 DB00129 | DB00129 | |
| 0.543 | 0.002 | 0.63 | Carbamoyl phosphate synthetase inhibitor | 0.63 0.001 DBMET02102 0.629 0.001 DBMET03078 0.113 0.017 DBMET03079 0.125 0.015 DBMET00494 0.544 0.002 DB00129 | DBMET02102 | |
| 0.542 | 0.005 | 0.691 | Phospholipase C inhibitor | 0.599 0.004 DBMET02102 0.324 0.016 DBMET03078 0.256 0.024 DBMET00494 0.691 0.003 DB00129 | DB00129 | |
| 0.534 | 0.005 | 0.57 | Growth hormone agonist | 0.548 0.004 DBMET02102 0.416 0.014 DBMET03078 0.57 0.004 DB00129 | DB00129 | |
| 0.539 | 0.01 | 0.686 | Platelet antagonist | 0.686 0.005 DBMET02102 0.584 0.007 DBMET03078 0.272 0.063 DBMET00494 0.554 0.009 DB00129 | DBMET02102 | |
| 0.548 | 0.023 | 0.548 | Immunostimulant | 0.525 0.026 DBMET02102 0.354 0.063 DBMET03078 0.18 0.133 DBMET03079 0.359 0.062 DBMET00494 0.54 0.024 DB00129 | ||
| 0.516 | 0.004 | 0.564 | Hematopoietic | 0.418 0.004 DBMET02102 0.093 0.044 DBMET03078 0.132 0.018 DBMET00494 0.564 0.004 DB00129 | DB00129 | |
| 0.526 | 0.021 | 0.576 | Histamine release inhibitor | 0.576 0.013 DBMET02102 0.482 0.035 DBMET03078 0.26 0.148 DBMET03079 0.383 0.084 DBMET00494 0.573 0.013 DB00129 | DBMET02102 | |
| 0.499 | 0.008 | 0.591 | Interleukin 2 agonist | 0.539 0.005 DBMET02102 0.424 0.021 DBMET03078 0.228 0.145 DBMET03079 0.442 0.017 DBMET00494 0.591 0.004 DB00129 | DB00129 | |
| 0.488 | 0.004 | 0.493 | Alcohol oxidase inhibitor | 0.436 0.004 DBMET02102 0.493 0.004 DBMET03078 0.144 0.011 DBMET03079 0.173 0.008 DBMET00494 0.459 0.004 DB00129 | DBMET03078 | |
| 0.473 | 0.006 | 0.585 | Thrombolytic | 0.442 0.008 DBMET02102 0.297 0.024 DBMET03078 0.318 0.021 DBMET00494 0.585 0.004 DB00129 | DB00129 | |
| 0.462 | 0.003 | 0.475 | Catalase inhibitor | 0.475 0.002 DBMET02102 0.409 0.004 DBMET03078 0.068 0.057 DBMET03079 0.087 0.044 DBMET00494 0.399 0.004 DB00129 | DBMET02102 | |
| 0.449 | 0.003 | 0.455 | Ferrochelatase inhibitor | 0.455 0.003 DBMET02102 0.452 0.003 DBMET03078 0.193 0.024 DBMET03079 0.307 0.007 DBMET00494 0.344 0.005 DB00129 | DBMET02102 | |
| 0.47 | 0.032 | 0.685 | 5 Hydroxytryptamine release stimulant | 0.63 0.012 DBMET02102 0.426 0.041 DBMET03078 0.315 0.065 DBMET03079 0.575 0.017 DBMET00494 0.685 0.008 DB00129 | DB00129 | |
| 0.461 | 0.035 | 0.508 | Antithrombotic | 0.502 0.029 DBMET02102 0.461 0.035 DBMET03078 0.42 0.045 DBMET00494 0.508 0.028 DB00129 | DB00129 | |
| 0.427 | 0.002 | 0.625 | NMDA receptor agonist | 0.461 0.002 DBMET02102 0.156 0.007 DBMET03078 0.066 0.04 DBMET03079 0.376 0.003 DBMET00494 0.625 0.002 DB00129 | DB00129 | |
| 0.439 | 0.016 | 0.439 | Insulysin inhibitor | 0.424 0.018 DBMET02102 0.365 0.029 DBMET03078 0.284 0.069 DBMET03079 0.437 0.017 DBMET00494 0.428 0.018 DB00129 | ||
| 0.421 | 0.002 | 0.507 | Argininosuccinate synthase inhibitor | 0.507 0.002 DBMET02102 0.306 0.004 DBMET03078 0.109 0.017 DBMET03079 0.147 0.012 DBMET00494 0.507 0.002 DB00129 | DB00129 | |
| 0.424 | 0.01 | 0.575 | 5 Hydroxytryptamine uptake stimulant | 0.575 0.003 DBMET02102 0.459 0.006 DBMET03078 0.292 0.049 DBMET03079 0.401 0.014 DBMET00494 0.517 0.004 DB00129 | DBMET02102 | |
| 0.424 | 0.014 | 0.458 | Anticoagulant | 0.429 0.014 DBMET02102 0.244 0.04 DBMET03078 0.288 0.03 DBMET00494 0.458 0.012 DB00129 | DB00129 | |
| 0.414 | 0.005 | 0.414 | Cell adhesion inhibitor | 0.405 0.005 DBMET02102 0.194 0.026 DBMET03078 0.191 0.027 DBMET00494 0.333 0.008 DB00129 | ||
| 0.418 | 0.015 | 0.418 | Transcription factor STAT inhibitor | 0.227 0.104 DBMET02102 0.187 0.158 DBMET00494 0.312 0.049 DB00129 | ||
| 0.404 | 0.004 | 0.583 | Aminopeptidase B inhibitor | 0.374 0.005 DBMET02102 0.243 0.014 DBMET03078 0.158 0.034 DBMET03079 0.251 0.013 DBMET00494 0.583 0.002 DB00129 | DB00129 | |
| 0.397 | 0.002 | 0.775 | Fumarate hydratase inhibitor | 0.478 0.002 DBMET02102 0.775 0.001 DBMET03078 0.041 0.018 DBMET03079 0.051 0.013 DBMET00494 0.231 0.003 DB00129 | DBMET03078 | |
| 0.411 | 0.017 | 0.411 | Transcription factor STAT3 inhibitor | 0.233 0.098 DBMET02102 0.196 0.14 DBMET03078 0.183 0.159 DBMET00494 0.29 0.059 DB00129 | ||
| 0.446 | 0.053 | 0.507 | 5 Hydroxytryptamine release inhibitor | 0.482 0.039 DBMET02102 0.451 0.051 DBMET03078 0.396 0.08 DBMET03079 0.507 0.03 DBMET00494 0.456 0.049 DB00129 | DBMET00494 | |
| 0.405 | 0.021 | 0.411 | DNA synthesis inhibitor | 0.411 0.02 DBMET02102 0.355 0.029 DBMET03078 0.256 0.062 DBMET03079 0.373 0.026 DBMET00494 0.385 0.024 DB00129 | DBMET02102 | |
| 0.384 | 0.002 | 0.621 | Glutamate (mGluR6) antagonist | 0.621 0.001 DBMET02102 0.17 0.003 DBMET03078 0.09 0.016 DBMET03079 0.193 0.003 DBMET00494 0.371 0.002 DB00129 | DBMET02102 | |
| 0.392 | 0.011 | 0.392 | DNA methylase inhibitor | 0.367 0.014 DBMET02102 0.312 0.024 DBMET03078 0.356 0.016 DBMET00494 0.341 0.018 DB00129 | ||
| 0.375 | 0.004 | 0.438 | Adenylate kinase inhibitor | 0.438 0.002 DBMET02102 0.42 0.003 DBMET03078 0.141 0.03 DBMET03079 0.169 0.021 DBMET00494 0.41 0.003 DB00129 | DBMET02102 | |
| 0.431 | 0.064 | 0.463 | Antibacterial | 0.393 0.08 DBMET02102 0.286 0.146 DBMET03078 0.247 0.179 DBMET03079 0.448 0.058 DBMET00494 0.463 0.052 DB00129 | DB00129 | |
| 0.367 | 0.004 | 0.406 | NMDA 2C receptor antagonist | 0.281 0.004 DBMET02102 0.069 0.034 DBMET03078 0.314 0.004 DBMET00494 0.406 0.003 DB00129 | DB00129 | |
| 0.367 | 0.007 | 0.367 | Cell wall synthesis inhibitor | 0.296 0.01 DBMET02102 0.209 0.026 DBMET03078 0.177 0.042 DBMET03079 0.325 0.009 DBMET00494 0.315 0.009 DB00129 | ||
| 0.363 | 0.003 | 0.492 | Phenylalanine 4-hydroxylase inhibitor | 0.43 0.003 DBMET02102 0.242 0.005 DBMET03078 0.101 0.025 DBMET03079 0.132 0.015 DBMET00494 0.492 0.002 DB00129 | DB00129 | |
| 0.36 | 0.005 | 0.903 | Succinate dehydrogenase inhibitor | 0.397 0.004 DBMET02102 0.903 0.002 DBMET03078 0.221 0.035 DBMET03079 0.249 0.023 DBMET00494 0.311 0.009 DB00129 | DBMET03078 | |
| 0.395 | 0.04 | 0.695 | Apoptosis antagonist | 0.606 0.009 DBMET02102 0.695 0.004 DBMET03078 0.248 0.129 DBMET03079 0.413 0.035 DB00129 | DBMET03078 | |
| 0.402 | 0.047 | 0.643 | Aldehyde oxidase inhibitor | 0.584 0.021 DBMET02102 0.643 0.014 DBMET03078 0.197 0.106 DBMET03079 0.356 0.054 DBMET00494 0.577 0.022 DB00129 | DBMET03078 | |
| 0.358 | 0.004 | 0.358 | Alcohol dehydrogenase inhibitor | 0.329 0.005 DBMET02102 0.229 0.009 DBMET03078 0.082 0.077 DBMET00494 0.248 0.008 DB00129 | ||
| 0.349 | 0.003 | 0.35 | Kainate receptor antagonist | 0.226 0.004 DBMET02102 0.047 0.023 DBMET03078 0.252 0.003 DBMET00494 0.35 0.003 DB00129 | DB00129 | |
| 0.344 | 0.002 | 0.483 | AMPA 4 receptor antagonist | 0.219 0.003 DBMET02102 0.049 0.016 DBMET03078 0.254 0.003 DBMET00494 0.483 0.002 DB00129 | DB00129 | |
| 0.343 | 0.004 | 0.489 | Leukotriene A4 hydrolase inhibitor | 0.489 0.003 DBMET02102 0.115 0.005 DBMET03078 0.177 0.004 DBMET00494 0.306 0.004 DB00129 | DBMET02102 | |
| 0.345 | 0.012 | 0.376 | Gastrin inhibitor | 0.348 0.011 DBMET02102 0.376 0.006 DBMET03078 0.228 0.107 DBMET03079 0.319 0.022 DBMET00494 0.301 0.032 DB00129 | DBMET03078 | |
| 0.333 | 0.002 | 0.333 | Glutamate (mGluR3) antagonist | 0.317 0.002 DBMET02102 0.072 0.006 DBMET03078 0.035 0.028 DBMET03079 0.143 0.004 DBMET00494 0.331 0.002 DB00129 | ||
| 0.332 | 0.004 | 0.601 | Phosphofructokinase-1 inhibitor | 0.478 0.002 DBMET02102 0.601 0.002 DBMET03078 0.127 0.023 DBMET03079 0.138 0.02 DBMET00494 0.362 0.004 DB00129 | DBMET03078 | |
| 0.331 | 0.005 | 0.8 | Porphobilinogen synthase inhibitor | 0.526 0.003 DBMET02102 0.8 0.002 DBMET03078 0.18 0.015 DBMET03079 0.179 0.015 DBMET00494 0.338 0.005 DB00129 | DBMET03078 | |
| 0.329 | 0.004 | 0.385 | Glycine transporter 2 inhibitor | 0.31 0.004 DBMET02102 0.385 0.003 DB00129 | DB00129 | |
| 0.33 | 0.005 | 0.383 | Aminoacyl-tRNA synthetase inhibitor | 0.326 0.005 DBMET02102 0.383 0.004 DB00129 | DB00129 | |
| 0.408 | 0.086 | 0.542 | Cyclophilin D inhibitor | 0.542 0.039 DBMET02102 0.311 0.153 DBMET03078 0.37 0.109 DBMET00494 0.344 0.126 DB00129 | DBMET02102 | |
| 0.356 | 0.036 | 0.408 | Sodium/bile acid cotransporter inhibitor | 0.367 0.03 DBMET02102 0.408 0.015 DBMET03078 0.224 0.157 DBMET00494 0.306 0.073 DB00129 | DBMET03078 | |
| 0.332 | 0.017 | 0.359 | DNA methyltransferase I inhibitor | 0.355 0.013 DBMET02102 0.324 0.019 DBMET03078 0.359 0.013 DBMET00494 0.292 0.029 DB00129 | DBMET00494 | |
| 0.326 | 0.011 | 0.347 | Neurotensin receptor agonist | 0.306 0.013 DBMET02102 0.197 0.036 DBMET03078 0.175 0.056 DBMET03079 0.225 0.026 DBMET00494 0.347 0.01 DB00129 | DB00129 | |
| 0.325 | 0.01 | 0.359 | Phospholipase A2 inhibitor | 0.275 0.018 DBMET02102 0.359 0.007 DBMET03078 0.121 0.116 DBMET00494 0.237 0.027 DB00129 | DBMET03078 | |
| 0.326 | 0.012 | 0.353 | Insulin sensitizer | 0.331 0.011 DBMET02102 0.267 0.026 DBMET03078 0.187 0.087 DBMET00494 0.353 0.009 DB00129 | DB00129 | |
| 0.319 | 0.005 | 0.319 | Integrin antagonist | 0.319 0.005 DBMET02102 0.16 0.009 DBMET03078 0.258 0.005 DBMET00494 0.304 0.005 DB00129 | ||
| 0.38 | 0.072 | 0.475 | Immunosuppressant | 0.475 0.04 DBMET02102 0.452 0.046 DBMET03078 0.246 0.151 DBMET00494 0.392 0.067 DB00129 | DBMET02102 | |
| 0.31 | 0.006 | 0.334 | Histone deacetylase SIRT1 inhibitor | 0.255 0.016 DBMET02102 0.147 0.064 DBMET00494 0.334 0.005 DB00129 | DB00129 | |
| 0.32 | 0.024 | 0.416 | Hepatoprotectant | 0.416 0.012 DBMET02102 0.289 0.033 DBMET03078 0.178 0.082 DBMET00494 0.315 0.026 DB00129 | DBMET02102 | |
| 0.366 | 0.072 | 0.433 | Transcription factor NF kappa B inhibitor | 0.433 0.056 DBMET02102 0.345 0.079 DBMET03078 0.194 0.175 DBMET00494 0.372 0.07 DB00129 | DBMET02102 | |
| 0.312 | 0.018 | 0.312 | Interferon gamma antagonist | 0.309 0.019 DBMET02102 0.243 0.03 DBMET03078 0.149 0.078 DBMET03079 0.2 0.041 DBMET00494 0.21 0.038 DB00129 | ||
| 0.296 | 0.005 | 0.619 | Triose-phosphate isomerase inhibitor | 0.406 0.003 DBMET02102 0.619 0.002 DBMET03078 0.15 0.02 DBMET03079 0.228 0.008 DBMET00494 0.244 0.007 DB00129 | DBMET03078 | |
| 0.288 | 0.004 | 0.581 | GABA aminotransferase inhibitor | 0.489 0.003 DBMET02102 0.18 0.005 DBMET03078 0.069 0.064 DBMET03079 0.103 0.025 DBMET00494 0.581 0.002 DB00129 | DB00129 | |
| 0.305 | 0.023 | 0.428 | Peptidyltransferase inhibitor | 0.308 0.022 DBMET02102 0.208 0.089 DBMET03078 0.192 0.11 DBMET00494 0.428 0.005 DB00129 | DB00129 | |
| 0.285 | 0.003 | 0.285 | Aminopeptidase I inhibitor | 0.262 0.004 DBMET02102 0.209 0.006 DBMET03078 0.126 0.018 DBMET03079 0.175 0.009 DBMET00494 0.257 0.004 DB00129 | ||
| 0.291 | 0.01 | 0.305 | Cystathionine beta-synthase inhibitor | 0.305 0.009 DBMET02102 0.243 0.016 DBMET03078 0.107 0.07 DBMET03079 0.104 0.072 DBMET00494 0.28 0.011 DB00129 | DBMET02102 | |
| 0.297 | 0.02 | 0.297 | Neuropeptide Y2 antagonist | 0.243 0.063 DBMET02102 0.18 0.159 DBMET03078 0.179 0.162 DBMET00494 0.289 0.024 DB00129 | ||
| 0.279 | 0.003 | 0.279 | Glutathione S-transferase inhibitor | 0.231 0.004 DBMET02102 0.123 0.021 DBMET03078 0.223 0.004 DB00129 | ||
| 0.28 | 0.005 | 0.296 | Carbonic anhydrase stimulant | 0.174 0.009 DBMET02102 0.083 0.024 DBMET03078 0.059 0.041 DBMET03079 0.079 0.026 DBMET00494 0.296 0.004 DB00129 | DB00129 | |
| 0.27 | 0.003 | 0.313 | AMPA 1 receptor antagonist | 0.117 0.005 DBMET02102 0.18 0.004 DBMET00494 0.313 0.003 DB00129 | DB00129 | |
| 0.284 | 0.017 | 0.354 | Hemostatic | 0.274 0.019 DBMET02102 0.127 0.101 DBMET03078 0.226 0.025 DBMET00494 0.354 0.011 DB00129 | DB00129 | |
| 0.286 | 0.019 | 0.324 | Bone formation stimulant | 0.3 0.017 DBMET02102 0.209 0.033 DBMET03078 0.136 0.071 DBMET00494 0.324 0.015 DB00129 | DB00129 | |
| 0.268 | 0.002 | 0.271 | Kainate receptor 1 antagonist | 0.177 0.003 DBMET02102 0.02 0.015 DBMET03078 0.213 0.003 DBMET00494 0.271 0.002 DB00129 | DB00129 | |
| 0.269 | 0.007 | 0.323 | Toll-Like receptor 2 antagonist | 0.264 0.007 DBMET02102 0.208 0.02 DBMET03078 0.146 0.055 DBMET00494 0.323 0.004 DB00129 | DB00129 | |
| 0.274 | 0.011 | 0.274 | Cathepsin H inhibitor | 0.222 0.017 DBMET02102 0.166 0.036 DBMET03078 0.137 0.057 DBMET03079 0.142 0.053 DBMET00494 0.25 0.014 DB00129 | ||
| 0.282 | 0.026 | 0.316 | Diuretic | 0.264 0.028 DBMET02102 0.169 0.061 DBMET03078 0.225 0.036 DBMET00494 0.316 0.02 DB00129 | DB00129 | |
| 0.26 | 0.006 | 0.344 | Cell adhesion molecule inhibitor | 0.344 0.005 DBMET02102 0.132 0.02 DBMET03078 0.106 0.031 DBMET00494 0.168 0.012 DB00129 | DBMET02102 | |
| 0.253 | 0.003 | 0.314 | Glutamate (mGluR4) antagonist | 0.257 0.003 DBMET02102 0.077 0.009 DBMET03078 0.048 0.023 DBMET03079 0.215 0.003 DBMET00494 0.314 0.002 DB00129 | DB00129 | |
| 0.273 | 0.023 | 0.273 | Thiol protease inhibitor | 0.207 0.037 DBMET02102 0.176 0.05 DBMET03078 0.166 0.057 DBMET00494 0.239 0.029 DB00129 | ||
| 0.265 | 0.017 | 0.294 | Adenylate cyclase inhibitor | 0.182 0.03 DBMET02102 0.265 0.017 DBMET03078 0.117 0.07 DBMET00494 0.294 0.014 DB00129 | DB00129 | |
| 0.284 | 0.039 | 0.284 | Calpain inhibitor | 0.203 0.111 DBMET02102 0.234 0.08 DBMET03078 0.221 0.094 DB00129 | ||
| 0.249 | 0.005 | 0.401 | Inducible nitric-oxide synthase inhibitor | 0.223 0.006 DBMET02102 0.075 0.071 DBMET03078 0.14 0.019 DBMET03079 0.136 0.019 DBMET00494 0.401 0.003 DB00129 | DB00129 | |
| 0.293 | 0.055 | 0.447 | Hypoglycemic | 0.447 0.021 DBMET02102 0.318 0.047 DBMET03078 0.165 0.155 DBMET00494 0.287 0.057 DB00129 | DBMET02102 | |
| 0.241 | 0.004 | 0.391 | NMDA 2A receptor antagonist | 0.164 0.006 DBMET02102 0.226 0.004 DBMET00494 0.391 0.003 DB00129 | DB00129 | |
| 0.241 | 0.005 | 0.285 | Folate antagonist | 0.285 0.004 DBMET02102 0.228 0.006 DBMET03078 0.091 0.085 DBMET00494 0.264 0.004 DB00129 | DBMET02102 | |
| 0.277 | 0.041 | 0.351 | Platelet adhesion inhibitor | 0.292 0.036 DBMET02102 0.351 0.019 DBMET03078 0.247 0.05 DBMET00494 0.302 0.033 DB00129 | DBMET03078 | |
| 0.24 | 0.006 | 0.24 | Vanilloid 1 agonist | 0.202 0.011 DBMET02102 0.204 0.011 DBMET03078 0.112 0.108 DBMET00494 0.224 0.008 DB00129 | ||
| 0.239 | 0.005 | 0.407 | Nitric-oxide synthase inhibitor | 0.199 0.009 DBMET02102 0.129 0.033 DBMET03079 0.17 0.016 DBMET00494 0.407 0.003 DB00129 | DB00129 | |
| 0.236 | 0.005 | 0.236 | Toll-Like receptor 2 agonist | 0.197 0.007 DBMET02102 0.076 0.017 DBMET03078 0.038 0.032 DBMET03079 0.038 0.031 DBMET00494 0.232 0.005 DB00129 | ||
| 0.312 | 0.084 | 0.58 | Cholesterol antagonist | 0.463 0.038 DBMET02102 0.58 0.021 DBMET03078 0.223 0.145 DBMET03079 0.332 0.072 DBMET00494 0.359 0.061 DB00129 | DBMET03078 | |
| 0.241 | 0.013 | 0.241 | Cathepsin G inhibitor | 0.204 0.016 DBMET02102 0.138 0.023 DBMET03078 0.086 0.039 DBMET00494 0.159 0.02 DB00129 | ||
| 0.232 | 0.004 | 0.243 | Biliverdin reductase inhibitor | 0.243 0.004 DBMET02102 0.242 0.004 DBMET03078 0.094 0.02 DBMET03079 0.138 0.011 DBMET00494 0.15 0.009 DB00129 | DBMET02102 | |
| 0.244 | 0.017 | 0.334 | Alkylator | 0.322 0.011 DBMET02102 0.142 0.051 DBMET03078 0.106 0.082 DBMET00494 0.334 0.011 DB00129 | DB00129 | |
| 0.23 | 0.003 | 0.361 | AMPA 3 receptor antagonist | 0.134 0.004 DBMET02102 0.028 0.022 DBMET03078 0.184 0.003 DBMET00494 0.361 0.002 DB00129 | DB00129 | |
| 0.226 | 0.002 | 0.259 | Glutamate (mGluR1) agonist | 0.259 0.002 DBMET02102 0.041 0.005 DBMET03078 0.03 0.01 DBMET03079 0.197 0.003 DBMET00494 0.177 0.003 DB00129 | DBMET02102 | |
| 0.227 | 0.004 | 0.227 | CD45 antagonist | 0.113 0.008 DBMET02102 0.074 0.014 DBMET03078 0.063 0.019 DBMET00494 0.067 0.017 DB00129 | ||
| 0.233 | 0.011 | 0.234 | Histone deacetylase class III inhibitor | 0.192 0.022 DBMET02102 0.234 0.011 DB00129 | DB00129 | |
| 0.225 | 0.004 | 0.225 | DOPA decarboxylase inhibitor | 0.224 0.004 DBMET02102 0.208 0.005 DBMET03078 0.135 0.031 DBMET03079 0.141 0.027 DBMET00494 0.211 0.005 DB00129 | ||
| 0.22 | 0.006 | 0.22 | Erythropoietin receptor agonist | 0.045 0.024 DBMET02102 0.167 0.007 DB00129 | ||
| 0.231 | 0.019 | 0.352 | Chelator | 0.352 0.008 DBMET02102 0.107 0.068 DBMET03078 0.096 0.084 DBMET00494 0.316 0.01 DB00129 | DBMET02102 | |
| 0.258 | 0.047 | 0.379 | Anesthetic general | 0.367 0.021 DBMET02102 0.379 0.019 DBMET03078 0.147 0.117 DBMET03079 0.211 0.069 DBMET00494 0.291 0.035 DB00129 | DBMET03078 | |
| 0.299 | 0.088 | 0.41 | Vasodilator, coronary | 0.296 0.091 DBMET02102 0.25 0.134 DBMET03078 0.209 0.174 DBMET03079 0.41 0.032 DBMET00494 0.37 0.046 DB00129 | DBMET00494 | |
| 0.219 | 0.01 | 0.3 | Mucolytic | 0.291 0.004 DBMET02102 0.3 0.004 DBMET03078 0.096 0.083 DBMET03079 0.194 0.015 DBMET00494 0.257 0.006 DB00129 | DBMET03078 | |
| 0.226 | 0.018 | 0.296 | Catenin beta inhibitor | 0.296 0.005 DBMET02102 0.259 0.009 DBMET03078 0.165 0.074 DBMET00494 0.156 0.092 DB00129 | DBMET02102 | |
| 0.302 | 0.096 | 0.588 | Vasodilator, peripheral | 0.428 0.047 DBMET02102 0.588 0.017 DBMET03078 0.214 0.16 DBMET03079 0.459 0.038 DBMET00494 0.322 0.086 DB00129 | DBMET03078 | |
| 0.277 | 0.071 | 0.446 | Antioxidant | 0.36 0.044 DBMET02102 0.446 0.027 DBMET03078 0.282 0.069 DB00129 | DBMET03078 | |
| 0.232 | 0.027 | 0.232 | Interleukin 6 antagonist | 0.167 0.068 DBMET02102 0.218 0.032 DB00129 | ||
| 0.207 | 0.002 | 0.252 | Glutamate (mGluR1a) agonist | 0.252 0.002 DBMET02102 0.096 0.004 DBMET03078 0.046 0.005 DBMET03079 0.069 0.004 DBMET00494 0.186 0.002 DB00129 | DBMET02102 | |
| 0.22 | 0.015 | 0.24 | Nav1.4 sodium channel blocker | 0.21 0.017 DBMET02102 0.103 0.072 DBMET03078 0.24 0.01 DB00129 | DB00129 | |
| 0.206 | 0.003 | 0.234 | Glutamate (mGluR group III) antagonist | 0.216 0.003 DBMET02102 0.066 0.011 DBMET03078 0.043 0.032 DBMET03079 0.171 0.003 DBMET00494 0.234 0.003 DB00129 | DB00129 | |
| 0.215 | 0.012 | 0.471 | NMDA receptor antagonist | 0.287 0.007 DBMET02102 0.471 0.004 DBMET00494 0.382 0.005 DB00129 | DBMET00494 | |
| 0.246 | 0.044 | 0.313 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.253 0.041 DBMET02102 0.313 0.02 DBMET03078 0.161 0.124 DBMET00494 0.206 0.067 DB00129 | DBMET03078 | |
| 0.207 | 0.006 | 0.237 | GP IIb/IIIa receptor antagonist | 0.225 0.005 DBMET02102 0.117 0.015 DBMET03078 0.067 0.025 DBMET00494 0.237 0.005 DB00129 | DB00129 | |
| 0.255 | 0.055 | 0.37 | Anticonvulsant | 0.269 0.05 DBMET02102 0.37 0.026 DBMET00494 0.267 0.051 DB00129 | DBMET00494 | |
| 0.225 | 0.025 | 0.255 | Insulin secretagoues | 0.255 0.018 DBMET02102 0.211 0.03 DBMET03078 0.153 0.072 DBMET00494 0.2 0.036 DB00129 | DBMET02102 | |
| 0.201 | 0.001 | 0.201 | Kainate receptor agonist | 0.201 0.001 DBMET02102 0.081 0.004 DBMET03078 0.057 0.009 DBMET03079 0.126 0.002 DBMET00494 0.191 0.002 DB00129 | ||
| 0.208 | 0.01 | 0.259 | Adenylate cyclase stimulant | 0.243 0.004 DBMET02102 0.218 0.008 DBMET03078 0.142 0.077 DBMET03079 0.192 0.018 DBMET00494 0.259 0.004 DB00129 | DB00129 | |
| 0.208 | 0.011 | 0.406 | GABA C receptor antagonist | 0.237 0.008 DBMET02102 0.206 0.012 DBMET03078 0.186 0.016 DBMET03079 0.283 0.005 DBMET00494 0.406 0.003 DB00129 | DB00129 | |
| 0.206 | 0.01 | 0.217 | Selectin antagonist | 0.217 0.01 DBMET02102 0.077 0.038 DBMET03078 0.153 0.017 DB00129 | DBMET02102 | |
| 0.259 | 0.065 | 0.453 | Free radical scavenger | 0.306 0.05 DBMET02102 0.453 0.021 DBMET03078 0.269 0.061 DB00129 | DBMET03078 | |
| 0.305 | 0.112 | 0.483 | GABA C receptor rho-3 antagonist | 0.38 0.071 DBMET02102 0.472 0.034 DBMET03078 0.483 0.031 DBMET03079 0.382 0.07 DBMET00494 0.419 0.053 DB00129 | DBMET03079 | |
| 0.194 | 0.001 | 0.314 | Glutamate (mGluR8) agonist | 0.314 0.001 DBMET02102 0.116 0.002 DBMET03078 0.049 0.013 DBMET03079 0.057 0.008 DBMET00494 0.186 0.001 DB00129 | DBMET02102 | |
| 0.257 | 0.065 | 0.319 | Vasodilator | 0.29 0.052 DBMET02102 0.226 0.085 DBMET03078 0.236 0.078 DBMET00494 0.319 0.042 DB00129 | DB00129 | |
| 0.207 | 0.016 | 0.246 | Cyclooxygenase 3 inhibitor | 0.207 0.016 DBMET02102 0.163 0.038 DBMET03078 0.109 0.091 DBMET03079 0.186 0.024 DBMET00494 0.246 0.009 DB00129 | DB00129 | |
| 0.214 | 0.025 | 0.389 | Aldehyde dehydrogenase inhibitor | 0.305 0.011 DBMET02102 0.389 0.006 DBMET03078 0.32 0.01 DB00129 | DBMET03078 | |
| 0.193 | 0.005 | 0.221 | Glutamate (mGluR7) agonist | 0.221 0.004 DBMET02102 0.125 0.025 DBMET03078 0.096 0.069 DBMET03079 0.106 0.049 DBMET00494 0.19 0.005 DB00129 | DBMET02102 | |
| 0.206 | 0.019 | 0.324 | Expectorant | 0.318 0.008 DBMET02102 0.324 0.007 DBMET03078 0.233 0.015 DBMET00494 0.255 0.012 DB00129 | DBMET03078 | |
| 0.191 | 0.004 | 0.26 | Glutamate (mGluR group III) agonist | 0.26 0.003 DBMET02102 0.053 0.022 DBMET03078 0.038 0.037 DBMET00494 0.177 0.004 DB00129 | DBMET02102 | |
| 0.197 | 0.011 | 0.204 | Creatine kinase inhibitor | 0.194 0.011 DBMET02102 0.204 0.01 DBMET03078 0.12 0.041 DBMET03079 0.15 0.024 DBMET00494 0.171 0.017 DB00129 | DBMET03078 | |
| 0.189 | 0.006 | 0.222 | Acyl-CoA dehydrogenase inhibitor | 0.166 0.008 DBMET02102 0.222 0.004 DBMET03078 0.078 0.023 DBMET03079 0.097 0.017 DBMET00494 0.154 0.009 DB00129 | DBMET03078 | |
| 0.19 | 0.01 | 0.237 | Antimetabolite | 0.237 0.008 DBMET02102 0.154 0.012 DBMET03078 0.051 0.031 DBMET00494 0.206 0.009 DB00129 | DBMET02102 | |
| 0.195 | 0.015 | 0.195 | Protease inhibitor | 0.136 0.037 DBMET02102 0.105 0.061 DBMET03078 0.133 0.039 DB00129 | ||
| 0.182 | 0.005 | 0.306 | NMDA receptor subunit 3B antagonist | 0.189 0.005 DBMET02102 0.045 0.029 DBMET03078 0.306 0.004 DBMET00494 0.253 0.004 DB00129 | DBMET00494 | |
| 0.187 | 0.01 | 0.306 | GABA C receptor rho-1 antagonist | 0.201 0.008 DBMET02102 0.178 0.012 DBMET03078 0.187 0.01 DBMET03079 0.256 0.004 DBMET00494 0.306 0.003 DB00129 | DB00129 | |
| 0.181 | 0.004 | 0.279 | AMPA 2 receptor antagonist | 0.15 0.004 DBMET02102 0.279 0.003 DBMET00494 0.225 0.003 DB00129 | DBMET00494 | |
| 0.187 | 0.011 | 0.22 | Prolactin inhibitor | 0.22 0.006 DBMET02102 0.187 0.011 DBMET03078 0.118 0.039 DBMET03079 0.177 0.013 DBMET00494 0.198 0.009 DB00129 | DBMET02102 | |
| 0.177 | 0.003 | 0.216 | Kainate receptor 2 antagonist | 0.173 0.003 DBMET02102 0.051 0.015 DBMET03078 0.216 0.003 DBMET00494 0.198 0.003 DB00129 | DBMET00494 | |
| 0.181 | 0.008 | 0.181 | Factor XII inhibitor | 0.107 0.031 DBMET02102 0.077 0.073 DBMET00494 0.145 0.014 DB00129 | ||
| 0.182 | 0.008 | 0.29 | Neurotensin receptor antagonist | 0.091 0.016 DBMET02102 0.04 0.037 DBMET00494 0.29 0.004 DB00129 | DB00129 | |
| 0.172 | 0.001 | 0.351 | Glutamate (mGluR6) agonist | 0.351 0.001 DBMET02102 0.045 0.002 DBMET03078 0.011 0.01 DBMET03079 0.015 0.006 DBMET00494 0.155 0.001 DB00129 | DBMET02102 | |
| 0.181 | 0.011 | 0.271 | NMDA 2 receptor antagonist | 0.118 0.024 DBMET02102 0.237 0.007 DBMET00494 0.271 0.005 DB00129 | DB00129 | |
| 0.209 | 0.041 | 0.278 | Amylase inhibitor | 0.237 0.032 DBMET02102 0.241 0.03 DBMET03078 0.14 0.069 DBMET03079 0.278 0.022 DBMET00494 0.251 0.028 DB00129 | DBMET00494 | |
| 0.183 | 0.017 | 0.328 | Photosensitizer | 0.227 0.008 DBMET02102 0.328 0.004 DBMET03078 0.207 0.011 DB00129 | DBMET03078 | |
| 0.172 | 0.007 | 0.4 | Ornithine decarboxylase inhibitor | 0.252 0.004 DBMET02102 0.165 0.008 DBMET03078 0.075 0.073 DBMET03079 0.105 0.039 DBMET00494 0.4 0.002 DB00129 | DB00129 | |
| 0.169 | 0.006 | 0.169 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET02102 | ||
| 0.23 | 0.068 | 0.397 | Pyruvate kinase inhibitor | 0.226 0.069 DBMET02102 0.397 0.021 DBMET03078 0.136 0.13 DB00129 | DBMET03078 | |
| 0.166 | 0.007 | 0.166 | Human rhinovirus A protease inhibitor | 0.066 0.031 DBMET02102 0.069 0.029 DB00129 | ||
| 0.167 | 0.009 | 0.167 | Ribonucleoside-diphosphate reductase inhibitor | 0.124 0.015 DBMET02102 0.102 0.019 DBMET03078 0.111 0.017 DB00129 | ||
| 0.16 | 0.003 | 0.437 | Lysine carboxypeptidase inhibitor | 0.265 0.002 DBMET02102 0.065 0.005 DBMET03078 0.028 0.018 DBMET03079 0.104 0.004 DBMET00494 0.437 0.001 DB00129 | DB00129 | |
| 0.161 | 0.005 | 0.161 | Cholecystokinin B agonist | 0.085 0.007 DBMET02102 0.046 0.018 DBMET03078 0.056 0.013 DB00129 | ||
| 0.172 | 0.016 | 0.202 | Heat shock protein 70 antagonist | 0.176 0.014 DBMET02102 0.155 0.035 DBMET03078 0.145 0.058 DBMET03079 0.175 0.015 DBMET00494 0.202 0.006 DB00129 | DB00129 | |
| 0.166 | 0.01 | 0.166 | Ribonucleotide reductase inhibitor | 0.123 0.016 DBMET02102 0.102 0.02 DBMET03078 0.123 0.016 DB00129 | ||
| 0.165 | 0.009 | 0.165 | Neuropeptide agonist | 0.092 0.029 DBMET02102 0.134 0.018 DB00129 | ||
| 0.16 | 0.005 | 0.196 | Sirtuin 1 inhibitor | 0.127 0.012 DBMET02102 0.196 0.004 DB00129 | DB00129 | |
| 0.224 | 0.07 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.232 0.062 DBMET02102 0.235 0.06 DBMET03078 0.219 0.075 DBMET03079 0.22 0.073 DBMET00494 0.183 0.128 DB00129 | DBMET03078 | |
| 0.232 | 0.08 | 0.271 | Antiamyloidogenic | 0.15 0.148 DBMET00494 0.271 0.062 DB00129 | DB00129 | |
| 0.328 | 0.176 | 0.475 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.321 0.186 DBMET02102 0.354 0.146 DBMET03078 0.449 0.062 DBMET03079 0.475 0.046 DBMET00494 0.282 0.239 DB00129 | DBMET00494 | |
| 0.165 | 0.013 | 0.179 | Factor V inhibitor | 0.179 0.009 DBMET02102 0.107 0.055 DBMET03078 0.095 0.081 DBMET00494 0.176 0.009 DB00129 | DBMET02102 | |
| 0.158 | 0.007 | 0.158 | Glucagon-like peptide 1 agonist | 0.116 0.015 DBMET02102 0.089 0.029 DBMET03078 0.139 0.011 DB00129 | ||
| 0.2 | 0.049 | 0.245 | Antipruritic | 0.2 0.049 DBMET02102 0.166 0.077 DBMET00494 0.245 0.026 DB00129 | DB00129 | |
| 0.165 | 0.014 | 0.22 | NADH dehydrogenase inhibitor | 0.213 0.009 DBMET02102 0.201 0.01 DBMET03078 0.121 0.028 DBMET03079 0.156 0.016 DBMET00494 0.22 0.009 DB00129 | DB00129 | |
| 0.154 | 0.004 | 0.162 | NMDA receptor glycine site agonist | 0.135 0.005 DBMET02102 0.091 0.021 DBMET03078 0.162 0.004 DBMET00494 0.154 0.004 DB00129 | DBMET00494 | |
| 0.166 | 0.017 | 0.169 | Opioid delta receptor antagonist | 0.113 0.027 DBMET02102 0.088 0.033 DBMET00494 0.169 0.016 DB00129 | DB00129 | |
| 0.168 | 0.021 | 0.173 | Opioid antagonist | 0.108 0.042 DBMET02102 0.115 0.039 DBMET00494 0.173 0.02 DB00129 | DB00129 | |
| 0.154 | 0.006 | 0.244 | Glycine receptor agonist | 0.211 0.004 DBMET02102 0.161 0.006 DBMET03078 0.072 0.05 DBMET03079 0.108 0.017 DBMET00494 0.244 0.003 DB00129 | DB00129 | |
| 0.151 | 0.005 | 0.353 | NMDA receptor subunit 3A antagonist | 0.165 0.005 DBMET02102 0.045 0.022 DBMET03078 0.353 0.003 DBMET00494 0.222 0.004 DB00129 | DBMET00494 | |
| 0.179 | 0.033 | 0.574 | Glutamate receptor antagonist | 0.228 0.019 DBMET02102 0.574 0.004 DBMET00494 0.277 0.012 DB00129 | DBMET00494 | |
| 0.147 | 0.002 | 0.26 | Arginase inhibitor | 0.214 0.001 DBMET02102 0.076 0.006 DBMET03078 0.04 0.022 DBMET03079 0.154 0.002 DBMET00494 0.26 0.001 DB00129 | DB00129 | |
| 0.149 | 0.005 | 0.149 | Macrophage elastase inhibitor | 0.106 0.009 DBMET02102 0.066 0.016 DBMET03078 0.073 0.014 DB00129 | ||
| 0.233 | 0.09 | 0.368 | DNA damaging | 0.336 0.045 DBMET02102 0.197 0.117 DBMET03078 0.368 0.036 DB00129 | DB00129 | |
| 0.149 | 0.007 | 0.149 | Protease 3C (Human rhinovirus) inhibitor | 0.102 0.015 DBMET02102 0.089 0.021 DBMET03078 0.067 0.04 DBMET00494 0.077 0.03 DB00129 | ||
| 0.207 | 0.065 | 0.26 | Non-steroidal antiinflammatory agent | 0.26 0.039 DBMET02102 0.244 0.045 DBMET03078 0.236 0.049 DB00129 | DBMET02102 | |
| 0.165 | 0.024 | 0.208 | Carbonic anhydrase III inhibitor | 0.195 0.017 DBMET02102 0.195 0.017 DBMET03078 0.208 0.015 DB00129 | DB00129 | |
| 0.179 | 0.038 | 0.327 | Neurotrophic factor | 0.327 0.007 DBMET00494 0.149 0.06 DB00129 | DBMET00494 | |
| 0.161 | 0.021 | 0.211 | Caspase 3 inhibitor | 0.178 0.014 DBMET02102 0.211 0.008 DBMET03078 0.127 0.05 DBMET00494 0.14 0.036 DB00129 | DBMET03078 | |
| 0.173 | 0.035 | 0.173 | Proteasome inhibitor | 0.128 0.06 DBMET02102 0.097 0.092 DBMET03078 0.139 0.053 DB00129 | ||
| 0.164 | 0.026 | 0.203 | Interleukin 8 antagonist | 0.167 0.025 DBMET02102 0.157 0.03 DBMET03078 0.125 0.055 DBMET00494 0.203 0.012 DB00129 | DB00129 | |
| 0.143 | 0.009 | 0.143 | Aminopeptidase microsomal inhibitor | 0.141 0.009 DBMET02102 0.138 0.01 DB00129 | ||
| 0.233 | 0.099 | 0.423 | Spasmolytic | 0.261 0.086 DBMET02102 0.216 0.108 DBMET03078 0.423 0.036 DBMET00494 0.33 0.059 DB00129 | DBMET00494 | |
| 0.209 | 0.075 | 0.236 | Nitric-oxide synthase stimulant | 0.233 0.046 DBMET02102 0.216 0.066 DBMET03078 0.236 0.044 DBMET03079 0.212 0.071 DBMET00494 0.225 0.054 DB00129 | DBMET03079 | |
| 0.15 | 0.017 | 0.208 | Glutamate receptor agonist | 0.174 0.014 DBMET02102 0.192 0.011 DBMET00494 0.208 0.01 DB00129 | DB00129 | |
| 0.148 | 0.016 | 0.148 | Transcription factor NF kappa B stimulant | 0.13 0.021 DBMET02102 0.148 0.016 DBMET03078 0.106 0.033 DB00129 | ||
| 0.136 | 0.005 | 0.191 | GABA B receptor agonist | 0.18 0.004 DBMET02102 0.186 0.004 DBMET03078 0.073 0.06 DBMET03079 0.098 0.018 DBMET00494 0.191 0.004 DB00129 | DB00129 | |
| 0.148 | 0.019 | 0.17 | Anabolic | 0.158 0.014 DBMET02102 0.17 0.01 DBMET03078 0.108 0.052 DBMET03079 0.104 0.058 DBMET00494 0.147 0.019 DB00129 | DBMET03078 | |
| 0.14 | 0.011 | 0.14 | Bombesin 2 receptor antagonist | 0.081 0.017 DBMET02102 0.048 0.036 DBMET03078 0.055 0.028 DBMET00494 0.09 0.015 DB00129 | ||
| 0.136 | 0.007 | 0.175 | AMPA receptor antagonist | 0.075 0.019 DBMET02102 0.133 0.007 DBMET00494 0.175 0.005 DB00129 | DB00129 | |
| 0.131 | 0.004 | 0.131 | Glutamate (mGluR7) antagonist | 0.129 0.004 DBMET02102 0.097 0.012 DBMET03078 0.082 0.025 DBMET03079 0.11 0.007 DBMET00494 0.122 0.004 DB00129 | ||
| 0.131 | 0.004 | 0.181 | Complement C3a chemotactic receptor antagonist | 0.114 0.006 DBMET02102 0.038 0.034 DBMET03078 0.181 0.003 DB00129 | DB00129 | |
| 0.131 | 0.005 | 0.891 | Aconitate hydratase inhibitor | 0.313 0.002 DBMET02102 0.891 0.001 DBMET03078 0.105 0.008 DBMET03079 0.097 0.009 DBMET00494 0.138 0.005 DB00129 | DBMET03078 | |
| 0.165 | 0.039 | 0.239 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.024 DBMET02102 0.166 0.038 DBMET03078 0.148 0.065 DBMET03079 0.239 0.004 DBMET00494 0.179 0.024 DB00129 | DBMET00494 | |
| 0.156 | 0.03 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.179 0.008 DBMET02102 0.193 0.004 DBMET03078 0.168 0.014 DBMET03079 0.17 0.013 DBMET00494 0.157 0.028 DB00129 | DBMET03078 | |
| 0.133 | 0.007 | 0.204 | Caspase 9 inhibitor | 0.145 0.006 DBMET02102 0.204 0.004 DBMET03078 0.088 0.019 DB00129 | DBMET03078 | |
| 0.149 | 0.024 | 0.149 | Urease inhibitor | 0.102 0.064 DBMET02102 0.117 0.048 DB00129 | ||
| 0.143 | 0.019 | 0.145 | Opioid mu receptor antagonist | 0.095 0.033 DBMET02102 0.081 0.039 DBMET00494 0.145 0.018 DB00129 | DB00129 | |
| 0.144 | 0.02 | 0.187 | Interleukin 1 beta converting enzyme inhibitor | 0.155 0.015 DBMET02102 0.187 0.008 DBMET03078 0.15 0.017 DB00129 | DBMET03078 | |
| 0.153 | 0.029 | 0.185 | DNA repair enzyme inhibitor | 0.151 0.03 DBMET02102 0.185 0.012 DBMET03078 0.145 0.036 DB00129 | DBMET03078 | |
| 0.178 | 0.056 | 0.244 | Arachidonic acid antagonist | 0.209 0.025 DBMET02102 0.244 0.007 DBMET03078 0.168 0.067 DBMET03079 0.155 0.083 DBMET00494 0.166 0.07 DB00129 | DBMET03078 | |
| 0.133 | 0.01 | 0.193 | Endothelin-converting enzyme inhibitor | 0.193 0.005 DBMET02102 0.08 0.018 DB00129 | DBMET02102 | |
| 0.127 | 0.005 | 0.138 | Integrin alpha4 antagonist | 0.138 0.005 DBMET02102 0.06 0.01 DBMET03078 0.052 0.011 DBMET00494 0.119 0.005 DB00129 | DBMET02102 | |
| 0.138 | 0.019 | 0.199 | Histamine N-methyltransferase inhibitor | 0.131 0.023 DBMET02102 0.08 0.067 DBMET03079 0.096 0.049 DBMET00494 0.199 0.005 DB00129 | DB00129 | |
| 0.164 | 0.045 | 0.166 | Neuropeptide Y1 antagonist | 0.137 0.086 DBMET02102 0.155 0.057 DBMET00494 0.166 0.044 DB00129 | DB00129 | |
| 0.125 | 0.006 | 0.193 | Angiotensin-converting enzyme inhibitor | 0.162 0.005 DBMET02102 0.073 0.017 DBMET03078 0.079 0.014 DBMET03079 0.193 0.004 DBMET00494 0.149 0.005 DB00129 | DBMET00494 | |
| 0.12 | 0.004 | 0.236 | Kainate receptor 5 antagonist | 0.131 0.004 DBMET02102 0.236 0.003 DBMET00494 0.132 0.004 DB00129 | DBMET00494 | |
| 0.121 | 0.005 | 0.121 | VLA-4 antagonist | 0.09 0.007 DBMET02102 0.063 0.01 DBMET03078 0.058 0.011 DBMET00494 0.119 0.005 DB00129 | ||
| 0.153 | 0.037 | 0.193 | Sphingosine 1-phosphate receptor 2 antagonist | 0.193 0.009 DBMET02102 0.165 0.025 DBMET03078 0.114 0.113 DBMET03079 0.16 0.029 DBMET00494 0.173 0.019 DB00129 | DBMET02102 | |
| 0.119 | 0.003 | 0.136 | Kainate receptor 3 antagonist | 0.134 0.003 DBMET02102 0.136 0.003 DBMET00494 0.136 0.003 DB00129 | DB00129 | |
| 0.119 | 0.004 | 0.141 | Thymidylate synthase inhibitor | 0.141 0.003 DBMET02102 0.074 0.01 DBMET03078 0.093 0.005 DB00129 | DBMET02102 | |
| 0.124 | 0.009 | 0.124 | Aminopeptidase N inhibitor | 0.122 0.009 DBMET02102 0.117 0.01 DB00129 | ||
| 0.128 | 0.014 | 0.187 | Sphingosine 1-phosphate receptor 4 agonist | 0.187 0.005 DBMET02102 0.144 0.01 DBMET03078 0.161 0.007 DB00129 | DBMET02102 | |
| 0.129 | 0.015 | 0.129 | Neutrophil collagenase inhibitor | 0.096 0.024 DBMET02102 0.061 0.05 DBMET03078 0.095 0.024 DBMET00494 0.087 0.028 DB00129 | ||
| 0.174 | 0.06 | 0.18 | Protein-tyrosine phosphatase inhibitor | 0.154 0.074 DBMET02102 0.18 0.056 DBMET03078 0.148 0.08 DBMET00494 | DBMET03078 | |
| 0.133 | 0.019 | 0.133 | Interleukin 12 antagonist | 0.099 0.055 DBMET02102 0.092 0.068 DBMET03078 | ||
| 0.115 | 0.002 | 0.135 | Glutamate (mGluR8) antagonist | 0.135 0.002 DBMET02102 0.064 0.005 DBMET03078 0.119 0.002 DBMET00494 0.115 0.002 DB00129 | DBMET02102 | |
| 0.147 | 0.036 | 0.188 | Sphingosine 1-phosphate receptor 4 antagonist | 0.16 0.026 DBMET02102 0.14 0.043 DBMET03078 0.107 0.101 DBMET03079 0.188 0.012 DBMET00494 0.139 0.045 DB00129 | DBMET00494 | |
| 0.134 | 0.024 | 0.134 | Metalloproteinase-2 inhibitor | 0.098 0.039 DBMET02102 0.07 0.065 DBMET03078 0.093 0.042 DBMET00494 0.111 0.033 DB00129 | ||
| 0.127 | 0.017 | 0.133 | Myeloperoxidase inhibitor | 0.107 0.028 DBMET02102 0.133 0.015 DB00129 | DB00129 | |
| 0.147 | 0.038 | 0.149 | Falcipain 3 inhibitor | 0.111 0.06 DBMET02102 0.096 0.074 DBMET03078 0.113 0.058 DBMET03079 0.129 0.048 DBMET00494 0.149 0.037 DB00129 | DB00129 | |
| 0.125 | 0.016 | 0.125 | Vanilloid agonist | 0.099 0.034 DBMET02102 0.117 0.02 DBMET03078 0.109 0.025 DB00129 | ||
| 0.19 | 0.083 | 0.275 | Amyloid beta aggregation inhibitor | 0.275 0.05 DB00129 | DB00129 | |
| 0.109 | 0.003 | 0.111 | Membrane dipeptidase inhibitor | 0.106 0.003 DBMET02102 0.101 0.004 DBMET03078 0.041 0.025 DBMET03079 0.072 0.007 DBMET00494 0.111 0.003 DB00129 | DB00129 | |
| 0.14 | 0.034 | 0.307 | Mediator release inhibitor | 0.169 0.021 DBMET02102 0.307 0.007 DBMET03078 0.135 0.036 DB00129 | DBMET03078 | |
| 0.11 | 0.004 | 0.195 | Glutamate (mGluR4) agonist | 0.195 0.003 DBMET02102 0.038 0.018 DBMET03078 0.098 0.004 DB00129 | DBMET02102 | |
| 0.123 | 0.018 | 0.16 | Glutamate (mGluR) agonist | 0.16 0.013 DBMET02102 0.135 0.016 DB00129 | DBMET02102 | |
| 0.125 | 0.021 | 0.199 | Somatostatin 1 agonist | 0.106 0.03 DBMET02102 0.166 0.01 DBMET00494 0.199 0.007 DB00129 | DB00129 | |
| 0.119 | 0.018 | 0.183 | Interferon agonist | 0.126 0.015 DBMET02102 0.102 0.027 DBMET03078 0.101 0.028 DBMET00494 0.183 0.007 DB00129 | DB00129 | |
| 0.133 | 0.032 | 0.305 | HIV-1 integrase (Overall Integration) inhibitor | 0.177 0.017 DBMET02102 0.305 0.004 DBMET03078 0.124 0.037 DBMET00494 0.137 0.031 DB00129 | DBMET03078 | |
| 0.104 | 0.005 | 0.118 | AICAR transformylase inhibitor | 0.118 0.004 DBMET02102 0.087 0.006 DBMET03078 0.041 0.037 DBMET03079 0.047 0.025 DBMET00494 0.084 0.007 DB00129 | DBMET02102 | |
| 0.101 | 0.002 | 0.152 | Glutamate (mGluR3) agonist | 0.152 0.001 DBMET02102 0.064 0.003 DBMET03078 0.033 0.021 DBMET03079 0.074 0.003 DBMET00494 0.096 0.002 DB00129 | DBMET02102 | |
| 0.162 | 0.064 | 0.224 | Acetylcholine M1 receptor antagonist | 0.129 0.096 DBMET02102 0.119 0.111 DBMET03079 0.217 0.035 DBMET00494 0.224 0.033 DB00129 | DB00129 | |
| 0.122 | 0.025 | 0.122 | Chymotrypsin inhibitor | 0.108 0.031 DBMET02102 0.097 0.038 DBMET03078 0.082 0.052 DB00129 | ||
| 0.103 | 0.006 | 0.167 | Alpha-mannosidase inhibitor | 0.095 0.007 DBMET02102 0.077 0.013 DBMET03078 0.068 0.019 DBMET03079 0.167 0.004 DBMET00494 0.124 0.004 DB00129 | DBMET00494 | |
| 0.161 | 0.068 | 0.199 | Melanin inhibitor | 0.185 0.048 DBMET02102 0.199 0.041 DBMET03078 0.161 0.068 DBMET00494 0.18 0.052 DB00129 | DBMET03078 | |
| 0.104 | 0.012 | 0.104 | Cathepsin E inhibitor | 0.063 0.037 DBMET02102 0.078 0.024 DBMET00494 0.056 0.046 DB00129 | ||
| 0.104 | 0.012 | 0.104 | Opioid mu receptor agonist | 0.063 0.022 DBMET02102 0.041 0.039 DBMET00494 0.104 0.013 DB00129 | ||
| 0.096 | 0.005 | 0.103 | Carbonic anhydrase I stimulant | 0.045 0.02 DBMET02102 0.103 0.004 DB00129 | DB00129 | |
| 0.155 | 0.065 | 0.231 | Protein kinase stimulant | 0.217 0.036 DBMET02102 0.231 0.032 DBMET03078 0.192 0.044 DBMET00494 0.229 0.032 DB00129 | DBMET03078 | |
| 0.113 | 0.024 | 0.151 | Keratolytic | 0.12 0.022 DBMET02102 0.151 0.014 DBMET03078 0.07 0.065 DBMET03079 0.085 0.043 DBMET00494 0.106 0.027 DB00129 | DBMET03078 | |
| 0.094 | 0.005 | 0.1 | Carbonic anhydrase II stimulant | 0.065 0.018 DBMET02102 0.1 0.005 DB00129 | DB00129 | |
| 0.097 | 0.01 | 0.097 | Nitric oxide donor | 0.097 0.01 DBMET02102 0.096 0.011 DB00129 | ||
| 0.097 | 0.01 | 0.097 | Calcitonin receptor agonist | 0.078 0.012 DBMET02102 0.042 0.019 DBMET03078 0.033 0.024 DBMET03079 0.048 0.017 DBMET00494 0.092 0.01 DB00129 | ||
| 0.13 | 0.043 | 0.136 | Transcription factor STAT6 inhibitor | 0.111 0.079 DBMET02102 0.109 0.083 DBMET03079 0.132 0.041 DBMET00494 0.136 0.036 DB00129 | DB00129 | |
| 0.114 | 0.027 | 0.31 | Glutamate release inhibitor | 0.149 0.01 DBMET02102 0.31 0.003 DBMET03078 0.092 0.057 DBMET03079 0.105 0.036 DBMET00494 0.13 0.016 DB00129 | DBMET03078 | |
| 0.137 | 0.052 | 0.177 | Monophenol monooxygenase inhibitor | 0.169 0.041 DBMET02102 0.177 0.039 DBMET03078 0.108 0.07 DB00129 | DBMET03078 | |
| 0.133 | 0.048 | 0.162 | Microtubule formation inhibitor | 0.155 0.035 DBMET02102 0.162 0.032 DBMET03078 0.111 0.072 DBMET03079 0.152 0.036 DBMET00494 0.12 0.06 DB00129 | DBMET03078 | |
| 0.091 | 0.006 | 0.092 | Lysophosphatidic acid 3 receptor antagonist | 0.092 0.006 DBMET02102 0.09 0.006 DBMET03078 0.046 0.043 DBMET00494 0.079 0.01 DB00129 | DBMET02102 | |
| 0.089 | 0.006 | 0.095 | Integrin alpha5beta1 antagonist | 0.061 0.011 DBMET02102 0.043 0.025 DBMET03078 0.095 0.005 DBMET00494 0.084 0.006 DB00129 | DBMET00494 | |
| 0.151 | 0.068 | 0.216 | Lipid peroxidase inhibitor | 0.216 0.036 DBMET02102 0.145 0.072 DBMET03078 0.123 0.09 DBMET00494 0.141 0.075 DB00129 | DBMET02102 | |
| 0.087 | 0.005 | 0.099 | Vitronectin receptor antagonist | 0.099 0.005 DBMET02102 0.047 0.007 DBMET03078 0.082 0.005 DB00129 | DBMET02102 | |
| 0.089 | 0.007 | 0.168 | Mannosidase inhibitor | 0.103 0.005 DBMET02102 0.077 0.009 DBMET03078 0.056 0.019 DBMET03079 0.168 0.004 DBMET00494 0.128 0.004 DB00129 | DBMET00494 | |
| 0.108 | 0.028 | 0.115 | Analgesic, opioid | 0.115 0.025 DBMET02102 0.097 0.033 DBMET00494 0.099 0.031 DB00129 | DBMET02102 | |
| 0.086 | 0.007 | 0.088 | Adenine nucleotide translocase inhibitor | 0.088 0.006 DBMET02102 0.055 0.04 DBMET03078 0.073 0.013 DBMET00494 0.081 0.009 DB00129 | DBMET02102 | |
| 0.084 | 0.005 | 0.105 | Caspase 2 inhibitor | 0.105 0.004 DBMET02102 0.081 0.006 DBMET03078 0.047 0.013 DB00129 | DBMET02102 | |
| 0.086 | 0.008 | 0.086 | Adenosine deaminase inhibitor | 0.08 0.009 DBMET02102 0.059 0.021 DBMET03078 0.065 0.017 DBMET03079 0.054 0.026 DBMET00494 0.081 0.009 DB00129 | ||
| 0.081 | 0.004 | 0.132 | Kainate receptor 4 antagonist | 0.087 0.004 DBMET02102 0.132 0.003 DBMET00494 0.087 0.004 DB00129 | DBMET00494 | |
| 0.092 | 0.016 | 0.121 | Interferon inducer | 0.09 0.017 DBMET02102 0.07 0.034 DBMET03078 0.069 0.036 DBMET00494 0.121 0.007 DB00129 | DB00129 | |
| 0.094 | 0.019 | 0.094 | Maillard reaction inhibitor | 0.086 0.022 DBMET02102 0.063 0.033 DB00129 | ||
| 0.082 | 0.008 | 0.34 | Glucose-6-phosphate isomerase inhibitor | 0.128 0.003 DBMET02102 0.34 0.001 DBMET03078 0.061 0.018 DBMET03079 0.059 0.019 DBMET00494 0.077 0.01 DB00129 | DBMET03078 | |
| 0.078 | 0.005 | 0.078 | Integrin beta7 antagonist | 0.028 0.01 DBMET02102 0.06 0.005 DB00129 | ||
| 0.103 | 0.03 | 0.103 | Metalloproteinase-9 inhibitor | 0.07 0.056 DBMET02102 0.075 0.048 DBMET00494 0.083 0.042 DB00129 | ||
| 0.114 | 0.042 | 0.185 | Electrolyte absorption antagonist | 0.157 0.017 DBMET02102 0.185 0.01 DBMET03078 0.119 0.037 DBMET03079 0.178 0.012 DBMET00494 0.13 0.029 DB00129 | DBMET03078 | |
| 0.075 | 0.004 | 0.112 | Calcium-sensing receptor agonist | 0.073 0.004 DBMET02102 0.112 0.003 DB00129 | DB00129 | |
| 0.074 | 0.003 | 0.074 | Aminopeptidase A inhibitor | 0.07 0.003 DBMET02102 0.026 0.008 DBMET03078 0.022 0.01 DBMET00494 0.047 0.004 DB00129 | ||
| 0.097 | 0.028 | 0.097 | Matrix metalloproteinase inhibitor | 0.067 0.046 DBMET02102 0.078 0.038 DBMET00494 0.082 0.036 DB00129 | ||
| 0.075 | 0.009 | 0.098 | Factor XIIIa inhibitor | 0.038 0.025 DBMET02102 0.036 0.027 DBMET03078 0.098 0.006 DB00129 | DB00129 | |
| 0.082 | 0.016 | 0.082 | Phosphorylase inhibitor | 0.06 0.025 DBMET02102 0.043 0.035 DBMET03078 0.064 0.023 DB00129 | ||
| 0.077 | 0.011 | 0.25 | Kinesin antagonist | 0.125 0.005 DBMET02102 0.25 0.004 DB00129 | DB00129 | |
| 0.077 | 0.011 | 0.25 | Kinesin-like protein 1 inhibitor | 0.125 0.005 DBMET02102 0.25 0.004 DB00129 | DB00129 | |
| 0.094 | 0.029 | 0.121 | Thrombin inhibitor | 0.096 0.028 DBMET02102 0.08 0.041 DBMET00494 0.121 0.018 DB00129 | DB00129 | |
| 0.082 | 0.018 | 0.092 | Opioid agonist | 0.05 0.039 DBMET02102 0.047 0.044 DBMET00494 0.092 0.015 DB00129 | DB00129 | |
| 0.099 | 0.036 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | 0.116 0.018 DBMET02102 0.113 0.021 DBMET03078 0.119 0.017 DBMET03079 0.099 0.037 DBMET00494 0.1 0.034 DB00129 | DBMET03079 | |
| 0.228 | 0.165 | 0.228 | Calpain 2 inhibitor | 0.206 0.182 DBMET03078 | ||
| 0.073 | 0.011 | 0.073 | Bombesin antagonist | 0.045 0.038 DB00129 | ||
| 0.074 | 0.013 | 0.081 | HCV NS3/NS4A protease inhibitor | 0.069 0.015 DBMET02102 0.081 0.01 DBMET03078 0.063 0.019 DBMET00494 0.055 0.026 DB00129 | DBMET03078 | |
| 0.075 | 0.013 | 0.075 | Cholecystokinin A antagonist | 0.069 0.015 DBMET02102 0.032 0.03 DB00129 | ||
| 0.069 | 0.008 | 0.077 | Neuraminidase (Influenza A) inhibitor | 0.055 0.017 DBMET02102 0.077 0.005 DBMET00494 0.063 0.01 DB00129 | DBMET00494 | |
| 0.08 | 0.02 | 0.107 | MDM2 inhibitor | 0.086 0.014 DBMET02102 0.107 0.005 DBMET03078 0.069 0.042 DBMET00494 0.07 0.037 DB00129 | DBMET03078 | |
| 0.064 | 0.004 | 0.101 | Tryptophan 5 hydroxylase inhibitor | 0.065 0.004 DBMET02102 0.043 0.011 DBMET03078 0.039 0.017 DBMET03079 0.101 0.002 DBMET00494 0.066 0.004 DB00129 | DBMET00494 | |
| 0.103 | 0.043 | 0.137 | Bile acid receptor antagonist | 0.114 0.026 DBMET02102 0.137 0.01 DBMET03078 0.092 0.067 DBMET00494 0.102 0.045 DB00129 | DBMET03078 | |
| 0.102 | 0.043 | 0.102 | Polo-like kinase-1 inhibitor | 0.086 0.07 DBMET02102 0.095 0.053 DBMET00494 | ||
| 0.078 | 0.02 | 0.078 | Protease activated receptor 1 antagonist | 0.077 0.02 DB00129 | ||
| 0.11 | 0.051 | 0.261 | UDP-glucose 4-epimerase inhibitor | 0.128 0.038 DBMET02102 0.261 0.012 DBMET03078 0.16 0.026 DBMET03079 0.19 0.019 DBMET00494 0.099 0.062 DB00129 | DBMET03078 | |
| 0.062 | 0.005 | 0.07 | AMPA receptor agonist | 0.062 0.005 DBMET02102 0.052 0.008 DBMET00494 0.07 0.004 DB00129 | DB00129 | |
| 0.068 | 0.011 | 0.068 | Oxytocin agonist | 0.061 0.016 DBMET02102 0.041 0.031 DBMET03078 0.039 0.033 DBMET03079 0.058 0.018 DBMET00494 0.066 0.012 DB00129 | ||
| 0.078 | 0.021 | 0.078 | Matrix metalloproteinase (membrane-type) inhibitor | 0.061 0.032 DBMET02102 0.05 0.046 DBMET03078 0.065 0.028 DBMET00494 0.068 0.026 DB00129 | ||
| 0.081 | 0.024 | 0.166 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET02102 0.166 0.006 DBMET00494 0.067 0.04 DB00129 | DBMET00494 | |
| 0.08 | 0.023 | 0.119 | Glutamate (mGluR1) antagonist | 0.1 0.016 DBMET00494 0.119 0.011 DB00129 | DB00129 | |
| 0.065 | 0.008 | 0.086 | Sirtuin 2 inhibitor | 0.086 0.005 DB00129 | DB00129 | |
| 0.063 | 0.007 | 0.173 | Endothelial nitric-oxide synthase inhibitor | 0.064 0.007 DBMET02102 0.035 0.017 DBMET00494 0.173 0.003 DB00129 | DB00129 | |
| 0.081 | 0.026 | 0.103 | Trypsin inhibitor | 0.076 0.029 DBMET02102 0.067 0.036 DBMET00494 0.103 0.016 DB00129 | DB00129 | |
| 0.069 | 0.014 | 0.07 | Cholecystokinin antagonist | 0.07 0.014 DBMET02102 | DBMET02102 | |
| 0.064 | 0.011 | 0.078 | Neurokinin 2 agonist | 0.049 0.02 DBMET02102 0.078 0.006 DB00129 | DB00129 | |
| 0.057 | 0.005 | 0.14 | Carboxypeptidase B inhibitor | 0.061 0.004 DBMET02102 0.037 0.016 DBMET03078 0.034 0.021 DBMET00494 0.14 0.002 DB00129 | DB00129 | |
| 0.074 | 0.022 | 0.118 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 DBMET02102 0.118 0.007 DB00129 | DB00129 | |
| 0.078 | 0.027 | 0.186 | Neuraminidase inhibitor | 0.186 0.004 DBMET00494 0.063 0.04 DB00129 | DBMET00494 | |
| 0.057 | 0.006 | 0.064 | Bradykinin B2 receptor agonist | 0.033 0.016 DBMET02102 0.064 0.005 DB00129 | DB00129 | |
| 0.058 | 0.008 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DBMET02102 0.059 0.008 DBMET03078 0.041 0.029 DBMET03079 0.051 0.014 DBMET00494 0.068 0.005 DB00129 | DBMET02102 | |
| 0.055 | 0.005 | 0.055 | Integrin alpha4beta7 antagonist | 0.046 0.005 DBMET02102 0.055 0.005 DB00129 | ||
| 0.052 | 0.002 | 0.053 | Carbonic anhydrase X inhibitor | 0.052 0.003 DBMET02102 0.053 0.002 DBMET03078 0.016 0.013 DBMET00494 0.048 0.003 DB00129 | DBMET03078 | |
| 0.052 | 0.002 | 0.053 | Carbonic anhydrase VIII inhibitor | 0.052 0.003 DBMET02102 0.053 0.002 DBMET03078 0.016 0.013 DBMET00494 0.048 0.003 DB00129 | DBMET03078 | |
| 0.056 | 0.006 | 0.056 | VCAM-1 antagonist | 0.053 0.008 DBMET02102 0.049 0.009 DBMET03078 0.054 0.007 DB00129 | ||
| 0.056 | 0.006 | 0.058 | VCAM antagonist | 0.053 0.008 DBMET02102 0.058 0.005 DBMET03078 0.053 0.007 DB00129 | DBMET03078 | |
| 0.073 | 0.025 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.06 0.05 DBMET00494 0.074 0.023 DB00129 | DB00129 | |
| 0.15 | 0.102 | 0.15 | 3C-like protease (Human coronavirus) inhibitor | 0.14 0.12 DBMET03079 0.146 0.108 DBMET00494 | ||
| 0.273 | 0.225 | 0.597 | Caspase 9 stimulant | 0.41 0.105 DBMET02102 0.597 0.037 DBMET03078 0.36 0.137 DBMET03079 0.341 0.153 DBMET00494 0.364 0.135 DB00129 | DBMET03078 | |
| 0.052 | 0.005 | 0.077 | Integrin alphaVbeta3 antagonist | 0.051 0.005 DBMET02102 0.039 0.005 DBMET03078 0.029 0.009 DBMET00494 0.077 0.004 DB00129 | DB00129 | |
| 0.052 | 0.006 | 0.054 | Integrin alpha1beta1 antagonist | 0.054 0.005 DBMET02102 0.054 0.005 DBMET03078 0.052 0.006 DBMET00494 0.049 0.008 DB00129 | DBMET03078 | |
| 0.113 | 0.067 | 0.184 | TRPA1 agonist | 0.137 0.041 DBMET02102 0.184 0.014 DBMET03078 0.105 0.08 DB00129 | DBMET03078 | |
| 0.056 | 0.011 | 0.091 | Prostacyclin antagonist | 0.091 0.005 DBMET02102 0.072 0.007 DBMET03078 0.05 0.013 DB00129 | DBMET02102 | |
| 0.085 | 0.041 | 0.091 | Histone deacetylase SIRT2 inhibitor | 0.091 0.036 DB00129 | DB00129 | |
| 0.049 | 0.004 | 0.278 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.278 0.003 DBMET02102 0.043 0.004 DBMET03078 0.044 0.004 DB00129 | DBMET02102 | |
| 0.126 | 0.081 | 0.126 | Interleukin 1 antagonist | |||
| 0.049 | 0.005 | 0.049 | Growth factor receptor-bound protein 2 antagonist | 0.037 0.019 DBMET02102 0.035 0.024 DB00129 | ||
| 0.066 | 0.022 | 0.082 | Epithelial sodium channel blocker | 0.059 0.03 DBMET02102 0.082 0.012 DB00129 | DB00129 | |
| 0.088 | 0.045 | 0.125 | Glycine receptor antagonist | 0.106 0.027 DBMET02102 0.117 0.02 DBMET03078 0.086 0.048 DBMET03079 0.125 0.016 DBMET00494 0.104 0.029 DB00129 | DBMET00494 | |
| 0.057 | 0.014 | 0.061 | Parathyroid hormone antagonist | 0.042 0.041 DBMET02102 0.061 0.011 DB00129 | DB00129 | |
| 0.08 | 0.037 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET02102 0.069 0.063 DBMET03078 0.088 0.024 DBMET03079 0.087 0.026 DBMET00494 0.101 0.013 DB00129 | DB00129 | |
| 0.079 | 0.036 | 0.101 | Phospholipase D inhibitor | 0.101 0.014 DBMET02102 0.099 0.015 DBMET03078 0.067 0.059 DBMET03079 0.088 0.024 DBMET00494 0.087 0.025 DB00129 | DBMET02102 | |
| 0.062 | 0.02 | 0.062 | Immunoglobulin Fc receptor antagonist | 0.057 0.033 DBMET02102 | ||
| 0.049 | 0.006 | 0.068 | Integrin beta3 antagonist | 0.056 0.006 DBMET02102 0.029 0.01 DBMET03078 0.025 0.011 DBMET00494 0.068 0.005 DB00129 | DB00129 | |
| 0.059 | 0.016 | 0.101 | Growth hormone release inhibitor | 0.042 0.029 DBMET02102 0.101 0.007 DB00129 | DB00129 | |
| 0.068 | 0.026 | 0.068 | Bombesin 3 receptor antagonist | |||
| 0.069 | 0.027 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DBMET02102 0.059 0.04 DBMET03078 0.066 0.03 DBMET00494 0.07 0.025 DB00129 | DBMET02102 | |
| 0.098 | 0.057 | 0.126 | Potassium channel (Ca-activated) activator | 0.123 0.039 DBMET02102 0.079 0.077 DBMET03078 0.126 0.038 DBMET00494 0.104 0.052 DB00129 | DBMET00494 | |
| 0.089 | 0.048 | 0.09 | 3C-Like protease (SARS coronavirus) inhibitor | 0.09 0.047 DBMET00494 | DBMET00494 | |
| 0.05 | 0.01 | 0.054 | Peptide deformylase inhibitor | 0.05 0.01 DBMET02102 0.038 0.015 DBMET03078 0.029 0.022 DBMET00494 0.054 0.009 DB00129 | DB00129 | |
| 0.052 | 0.012 | 0.06 | Glucagon-like peptide 1 receptor antagonist | 0.06 0.009 DBMET02102 0.042 0.022 DBMET03078 0.042 0.022 DB00129 | DBMET02102 | |
| 0.074 | 0.034 | 0.083 | Exportin-1 inhibitor | 0.064 0.058 DBMET02102 0.083 0.021 DBMET03078 0.075 0.033 DBMET03079 | DBMET03078 | |
| 0.109 | 0.07 | 0.148 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 DBMET02102 0.148 0.046 DBMET03078 0.091 0.088 DBMET00494 | DBMET03078 | |
| 0.046 | 0.008 | 0.046 | Cholecystokinin agonist | 0.021 0.012 DBMET02102 | ||
| 0.067 | 0.029 | 0.067 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.044 | 0.007 | 0.044 | LFA antagonist | 0.028 0.019 DBMET02102 0.043 0.007 DBMET00494 0.038 0.009 DB00129 | ||
| 0.06 | 0.024 | 0.06 | Metalloproteinase-3 inhibitor | 0.051 0.032 DBMET02102 0.055 0.028 DBMET00494 0.056 0.027 DB00129 | ||
| 0.055 | 0.019 | 0.055 | Factor VIIa inhibitor | 0.034 0.032 DB00129 | ||
| 0.041 | 0.005 | 0.041 | Aminopeptidase P inhibitor | 0.03 0.01 DBMET02102 0.025 0.014 DBMET00494 0.026 0.013 DB00129 | ||
| 0.046 | 0.011 | 0.106 | Dipeptidyl peptidase II inhibitor | 0.055 0.008 DBMET02102 0.047 0.01 DBMET00494 0.106 0.004 DB00129 | DB00129 | |
| 0.112 | 0.076 | 0.124 | Beta amyloid protein antagonist | 0.105 0.083 DBMET02102 0.124 0.063 DB00129 | DB00129 | |
| 0.06 | 0.025 | 0.079 | Dipeptidyl peptidase inhibitor | 0.061 0.025 DBMET02102 0.077 0.015 DBMET00494 0.079 0.014 DB00129 | DB00129 | |
| 0.059 | 0.025 | 0.059 | Vanilloid 2 antagonist | |||
| 0.101 | 0.067 | 0.186 | Toll-Like receptor 4 antagonist | 0.115 0.048 DBMET02102 0.186 0.008 DBMET03078 0.103 0.064 DB00129 | DBMET03078 | |
| 0.047 | 0.013 | 0.182 | Integrin alpha2 antagonist | 0.053 0.01 DBMET02102 0.046 0.014 DBMET03078 0.042 0.018 DBMET03079 0.182 0.002 DBMET00494 0.058 0.008 DB00129 | DBMET00494 | |
| 0.125 | 0.092 | 0.16 | Mannose-6-phosphate isomerase inhibitor | 0.13 0.085 DBMET02102 0.16 0.057 DBMET03078 | DBMET03078 | |
| 0.118 | 0.086 | 0.138 | Nav1.2 sodium channel blocker | 0.138 0.065 DB00129 | DB00129 | |
| 0.064 | 0.032 | 0.112 | Sphingosine kinase inhibitor | 0.075 0.02 DBMET02102 0.061 0.037 DBMET03078 0.112 0.005 DBMET00494 0.064 0.033 DB00129 | DBMET00494 | |
| 0.049 | 0.017 | 0.052 | Glutamate (mGluR group II) antagonist | 0.052 0.015 DBMET02102 0.051 0.015 DBMET00494 0.048 0.017 DB00129 | DBMET02102 | |
| 0.042 | 0.01 | 0.043 | Methionyl aminopeptidase 1 inhibitor | 0.043 0.01 DBMET02102 0.032 0.021 DB00129 | DBMET02102 | |
| 0.062 | 0.031 | 0.062 | Kallikrein 1 inhibitor | 0.057 0.038 DB00129 | ||
| 0.036 | 0.005 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 DBMET02102 0.033 0.007 DBMET03078 0.024 0.022 DBMET00494 0.046 0.003 DB00129 | DB00129 | |
| 0.039 | 0.008 | 0.039 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.029 0.015 DBMET02102 0.026 0.022 DBMET00494 0.037 0.009 DB00129 | ||
| 0.037 | 0.007 | 0.041 | Lysophosphatidic acid receptor 1 agonist | 0.04 0.005 DBMET02102 0.041 0.005 DBMET03078 0.025 0.017 DBMET00494 0.034 0.008 DB00129 | DBMET03078 | |
| 0.054 | 0.024 | 0.054 | Collagenase inhibitor | 0.054 0.024 DBMET02102 0.052 0.028 DB00129 | ||
| 0.043 | 0.013 | 0.043 | Cholecystokinin B antagonist | 0.043 0.013 DBMET02102 | ||
| 0.035 | 0.005 | 0.035 | Integrin alphaVbeta1 antagonist | 0.032 0.005 DBMET02102 0.025 0.008 DBMET03078 0.024 0.009 DBMET00494 0.035 0.005 DB00129 | ||
| 0.039 | 0.009 | 0.094 | Neutral endopeptidase inhibitor | 0.094 0.005 DBMET02102 0.027 0.012 DB00129 | DBMET02102 | |
| 0.034 | 0.005 | 0.034 | ICAM 1 antagonist | 0.026 0.01 DBMET00494 0.026 0.01 DB00129 | ||
| 0.05 | 0.02 | 0.108 | Somatostatin 1 antagonist | 0.046 0.022 DBMET00494 0.108 0.006 DB00129 | DB00129 | |
| 0.052 | 0.023 | 0.056 | Carbonic anhydrase IV inhibitor | 0.056 0.021 DB00129 | DB00129 | |
| 0.038 | 0.01 | 0.067 | Urotensin II agonist | 0.035 0.012 DBMET02102 0.067 0.004 DB00129 | DB00129 | |
| 0.049 | 0.021 | 0.073 | Sphingosine 1-phosphate receptor 1 agonist | 0.073 0.008 DBMET02102 0.052 0.018 DBMET03078 0.046 0.024 DBMET00494 0.058 0.014 DB00129 | DBMET02102 | |
| 0.039 | 0.012 | 0.047 | Thrombin receptor antagonist | 0.027 0.022 DBMET02102 0.047 0.01 DB00129 | DB00129 | |
| 0.061 | 0.033 | 0.13 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 DBMET02102 0.13 0.01 DBMET03078 0.072 0.024 DBMET03079 0.053 0.043 DBMET00494 0.066 0.028 DB00129 | DBMET03078 | |
| 0.042 | 0.014 | 0.061 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.039 0.018 DBMET02102 0.061 0.006 DBMET03078 | DBMET03078 | |
| 0.044 | 0.017 | 0.048 | Opioid delta receptor agonist | 0.033 0.029 DBMET02102 0.048 0.014 DB00129 | DB00129 | |
| 0.031 | 0.003 | 0.072 | Tryptophan hydroxylase 1 inhibitor | 0.028 0.004 DBMET02102 0.072 0.002 DBMET00494 0.032 0.003 DB00129 | DBMET00494 | |
| 0.059 | 0.032 | 0.059 | Matrix metalloproteinase 1 inhibitor | 0.051 0.038 DBMET00494 0.055 0.035 DB00129 | ||
| 0.076 | 0.049 | 0.101 | Vanilloid 4 agonist | 0.098 0.018 DBMET02102 0.101 0.016 DBMET03078 0.074 0.053 DBMET03079 0.081 0.038 DBMET00494 0.083 0.035 DB00129 | DBMET03078 | |
| 0.049 | 0.022 | 0.064 | Dipeptidyl peptidase IV inhibitor | 0.051 0.019 DBMET02102 0.064 0.011 DBMET00494 0.056 0.015 DB00129 | DBMET00494 | |
| 0.035 | 0.009 | 0.035 | Vasopressin 1A agonist | 0.033 0.012 DB00129 | ||
| 0.033 | 0.008 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DB00129 | ||
| 0.081 | 0.056 | 0.145 | Carbonic anhydrase VI inhibitor | 0.102 0.038 DBMET02102 0.145 0.022 DBMET03078 0.123 0.028 DB00129 | DBMET03078 | |
| 0.155 | 0.131 | 0.242 | Neurotrophic factor enhancer | 0.2 0.076 DBMET02102 0.242 0.043 DBMET03078 | DBMET03078 | |
| 0.063 | 0.038 | 0.063 | Collagenase 3 inhibitor | 0.058 0.044 DBMET00494 | ||
| 0.063 | 0.039 | 0.064 | Beta 2 adrenoreceptor agonist | 0.062 0.042 DBMET00494 0.064 0.036 DB00129 | DB00129 | |
| 0.033 | 0.01 | 0.041 | Thyroid hormone agonist | 0.041 0.006 DBMET02102 0.038 0.007 DBMET03078 0.031 0.012 DB00129 | DBMET02102 | |
| 0.034 | 0.011 | 0.042 | Purinergic P2Y15 antagonist | 0.032 0.013 DBMET02102 0.029 0.019 DBMET03078 0.028 0.022 DBMET03079 0.042 0.005 DB00129 | DB00129 | |
| 0.045 | 0.022 | 0.045 | Melanocortin 1 antagonist | 0.036 0.028 DBMET00494 0.045 0.022 DB00129 | ||
| 0.05 | 0.027 | 0.075 | Farnesyltransferase inhibitor | 0.075 0.014 DBMET02102 0.041 0.039 DB00129 | DBMET02102 | |
| 0.033 | 0.01 | 0.137 | Integrin alpha2beta1 antagonist | 0.031 0.012 DBMET02102 0.026 0.019 DBMET03078 0.031 0.011 DBMET03079 0.137 0.003 DBMET00494 0.041 0.005 DB00129 | DBMET00494 | |
| 0.028 | 0.005 | 0.034 | Caspase 8 inhibitor | 0.027 0.006 DBMET02102 0.034 0.004 DBMET03078 0.021 0.011 DB00129 | DBMET03078 | |
| 0.029 | 0.006 | 0.035 | Isoleucine-tRNA ligase inhibitor | 0.035 0.004 DBMET02102 0.026 0.01 DBMET03078 0.026 0.009 DB00129 | DBMET02102 | |
| 0.028 | 0.005 | 0.047 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 DBMET02102 0.021 0.014 DBMET03078 0.022 0.013 DBMET03079 0.047 0.003 DBMET00494 0.027 0.006 DB00129 | DBMET00494 | |
| 0.034 | 0.011 | 0.041 | Growth hormone releasing factor antagonist | 0.041 0.009 DB00129 | DB00129 | |
| 0.047 | 0.025 | 0.047 | HIV-1 protease inhibitor | |||
| 0.04 | 0.017 | 0.046 | Trypsin I inhibitor | 0.038 0.019 DBMET02102 0.031 0.024 DBMET00494 0.046 0.014 DB00129 | DB00129 | |
| 0.029 | 0.006 | 0.029 | Glucagon agonist | 0.02 0.008 DB00129 | ||
| 0.04 | 0.019 | 0.116 | Somatostatin 5 agonist | 0.116 0.004 DB00129 | DB00129 | |
| 0.027 | 0.005 | 0.027 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET02102 0.018 0.011 DBMET03078 0.025 0.006 DB00129 | ||
| 0.091 | 0.07 | 0.112 | Sphingomyelinase inhibitor | 0.112 0.047 DBMET00494 0.098 0.062 DB00129 | DBMET00494 | |
| 0.025 | 0.004 | 0.025 | Integrin alphaVbeta6 antagonist | 0.018 0.007 DBMET02102 0.019 0.006 DBMET00494 0.025 0.004 DB00129 | ||
| 0.046 | 0.025 | 0.073 | Dihydrofolate reductase inhibitor | 0.073 0.005 DBMET02102 0.045 0.027 DBMET03078 0.062 0.009 DB00129 | DBMET02102 | |
| 0.029 | 0.009 | 0.029 | Integrin beta5 antagonist | 0.027 0.01 DBMET02102 0.023 0.012 DBMET03078 0.027 0.01 DBMET00494 0.026 0.01 DB00129 | ||
| 0.024 | 0.005 | 0.024 | Carbonic anhydrase IV stimulant | 0.021 0.006 DB00129 | ||
| 0.037 | 0.017 | 0.216 | HCV polyprotein inhibitor | 0.034 0.023 DBMET02102 0.216 0.002 DBMET03078 0.036 0.019 DB00129 | DBMET03078 | |
| 0.033 | 0.014 | 0.146 | NMDA 2D receptor antagonist | 0.03 0.015 DBMET02102 0.146 0.003 DBMET00494 0.029 0.017 DB00129 | DBMET00494 | |
| 0.036 | 0.017 | 0.036 | Factor VII inhibitor | 0.027 0.023 DBMET02102 0.032 0.019 DB00129 | ||
| 0.056 | 0.037 | 0.103 | Sphingosine 1-phosphate receptor 1 antagonist | 0.089 0.012 DBMET02102 0.103 0.009 DBMET03078 0.064 0.024 DBMET00494 0.063 0.025 DB00129 | DBMET03078 | |
| 0.04 | 0.022 | 0.04 | Bombesin 1 receptor antagonist | |||
| 0.049 | 0.031 | 0.059 | Melanocortin antagonist | 0.059 0.021 DBMET00494 0.057 0.023 DB00129 | DBMET00494 | |
| 0.044 | 0.027 | 0.069 | GHS receptor agonist | 0.069 0.009 DB00129 | DB00129 | |
| 0.069 | 0.051 | 0.069 | Secretase beta inhibitor | |||
| 0.027 | 0.009 | 0.027 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.022 | 0.005 | 0.033 | CXC chemokine 4 receptor agonist | 0.016 0.01 DBMET02102 0.033 0.003 DB00129 | DB00129 | |
| 0.044 | 0.027 | 0.061 | Melanocortin 4 antagonist | 0.061 0.018 DBMET00494 0.052 0.022 DB00129 | DBMET00494 | |
| 0.036 | 0.019 | 0.036 | Adenosine uptake inhibitor | 0.033 0.031 DBMET02102 | ||
| 0.045 | 0.028 | 0.057 | Leukocyte elastase inhibitor | 0.044 0.029 DBMET02102 0.046 0.027 DBMET03078 0.057 0.02 DBMET00494 | DBMET00494 | |
| 0.045 | 0.029 | 0.114 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 DBMET03079 0.114 0.009 DBMET00494 0.049 0.026 DB00129 | DBMET00494 | |
| 0.024 | 0.007 | 0.024 | KiSS-1 receptor antagonist | 0.02 0.009 DB00129 | ||
| 0.027 | 0.011 | 0.027 | Neurokinin 1 agonist | 0.02 0.015 DBMET02102 0.027 0.011 DB00129 | ||
| 0.022 | 0.006 | 0.027 | Telomerase stimulant | 0.027 0.004 DBMET02102 0.021 0.006 DBMET03078 0.022 0.006 DB00129 | DBMET02102 | |
| 0.081 | 0.065 | 0.12 | Estrogen-related receptor beta agonist | 0.097 0.029 DBMET02102 0.12 0.01 DBMET03078 0.087 0.047 DB00129 | DBMET03078 | |
| 0.036 | 0.021 | 0.045 | Growth hormone releasing factor agonist | 0.045 0.015 DB00129 | DB00129 | |
| 0.022 | 0.008 | 0.022 | Cholecystokinin A agonist | 0.015 0.012 DBMET02102 | ||
| 0.034 | 0.019 | 0.127 | Somatostatin 2 antagonist | 0.127 0.005 DB00129 | DB00129 | |
| 0.029 | 0.015 | 0.029 | Antidiuretic hormone agonist | |||
| 0.019 | 0.005 | 0.281 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.007 DBMET02102 0.281 0.002 DBMET03078 0.011 0.01 DB00129 | DBMET03078 | |
| 0.044 | 0.03 | 0.077 | Geranyltranstransferase inhibitor | 0.057 0.016 DBMET02102 0.053 0.019 DBMET03078 0.059 0.015 DBMET00494 0.077 0.005 DB00129 | DB00129 | |
| 0.04 | 0.026 | 0.058 | Dihydropteroate synthase inhibitor | 0.058 0.013 DBMET02102 0.053 0.015 DBMET03078 0.057 0.013 DB00129 | DBMET02102 | |
| 0.025 | 0.012 | 0.025 | Geranylgeranyltransferase inhibitor | 0.024 0.013 DBMET02102 0.02 0.019 DB00129 | ||
| 0.043 | 0.03 | 0.053 | Histamine H2 receptor agonist | 0.053 0.019 DB00129 | DB00129 | |
| 0.024 | 0.011 | 0.024 | Vasopressin 1 agonist | 0.021 0.017 DB00129 | ||
| 0.017 | 0.005 | 0.02 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DBMET02102 0.02 0.004 DBMET03078 0.014 0.007 DB00129 | DBMET03078 | |
| 0.033 | 0.022 | 0.102 | Somatostatin 5 antagonist | 0.041 0.018 DBMET00494 0.102 0.006 DB00129 | DB00129 | |
| 0.049 | 0.037 | 0.092 | Prolyl endopeptidase inhibitor | 0.046 0.042 DBMET02102 0.058 0.027 DBMET03078 0.051 0.034 DBMET03079 0.092 0.008 DBMET00494 0.047 0.041 DB00129 | DBMET00494 | |
| 0.041 | 0.03 | 0.077 | Sphingosine kinase 1 inhibitor | 0.045 0.022 DBMET02102 0.077 0.005 DBMET00494 0.039 0.033 DB00129 | DBMET00494 | |
| 0.059 | 0.048 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 DBMET02102 0.068 0.032 DB00129 | DB00129 | |
| 0.02 | 0.009 | 0.026 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.005 DBMET02102 0.026 0.004 DBMET03078 0.018 0.014 DBMET00494 0.02 0.009 DB00129 | DBMET03078 | |
| 0.057 | 0.046 | 0.066 | Cyclin A1 inhibitor | 0.066 0.027 DB00129 | DB00129 | |
| 0.028 | 0.017 | 0.029 | Motilin receptor antagonist | 0.029 0.017 DBMET00494 | DBMET00494 | |
| 0.098 | 0.088 | 0.376 | DNA polymerase I inhibitor | 0.163 0.042 DBMET02102 0.376 0.007 DBMET03078 0.096 0.09 DB00129 | DBMET03078 | |
| 0.017 | 0.007 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.022 0.005 DBMET02102 0.024 0.004 DBMET03078 0.016 0.007 DB00129 | DBMET03078 | |
| 0.043 | 0.033 | 0.073 | Sphingosine 1-phosphate receptor agonist | 0.073 0.01 DBMET02102 0.054 0.022 DBMET03078 0.052 0.023 DBMET00494 0.055 0.02 DB00129 | DBMET02102 | |
| 0.021 | 0.011 | 0.021 | Protease activated receptor agonist | 0.018 0.012 DB00129 | ||
| 0.145 | 0.135 | 0.256 | Platelet aggregation inhibitor | 0.256 0.049 DBMET02102 0.218 0.069 DBMET03078 0.182 0.096 DB00129 | DBMET02102 | |
| 0.042 | 0.032 | 0.075 | GABA B receptor antagonist | 0.068 0.009 DBMET02102 0.074 0.007 DBMET03078 0.064 0.01 DBMET00494 0.075 0.007 DB00129 | DB00129 | |
| 0.025 | 0.016 | 0.062 | NMDA receptor glycine site antagonist | 0.062 0.005 DBMET00494 | DBMET00494 | |
| 0.019 | 0.01 | 0.039 | Angiotensin-converting enzyme 2 inhibitor | 0.039 0.004 DBMET03078 0.021 0.008 DBMET00494 0.019 0.011 DB00129 | DBMET03078 | |
| 0.019 | 0.01 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.012 DBMET02102 0.018 0.015 DB00129 | ||
| 0.015 | 0.006 | 0.021 | Integrin beta2 antagonist | 0.021 0.005 DBMET00494 | DBMET00494 | |
| 0.019 | 0.01 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.009 DBMET02102 0.016 0.015 DBMET03079 | DBMET02102 | |
| 0.014 | 0.005 | 0.048 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DBMET02102 0.048 0.003 DB00129 | DB00129 | |
| 0.023 | 0.015 | 0.076 | Prostaglandin F2 alpha agonist | 0.032 0.008 DBMET02102 0.076 0.003 DBMET03078 | DBMET03078 | |
| 0.017 | 0.009 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 DBMET02102 0.015 0.012 DBMET03078 0.017 0.009 DB00129 | DBMET02102 | |
| 0.011 | 0.003 | 0.028 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.028 0.002 DBMET02102 0.012 0.003 DBMET03078 0.01 0.004 DB00129 | DBMET02102 | |
| 0.017 | 0.01 | 0.025 | Dipeptidyl peptidase IX inhibitor | 0.021 0.008 DBMET02102 0.025 0.007 DB00129 | DB00129 | |
| 0.038 | 0.031 | 0.071 | Dopamine D5 agonist | 0.055 0.014 DBMET02102 0.055 0.014 DBMET03078 0.071 0.008 DBMET00494 0.065 0.01 DB00129 | DBMET00494 | |
| 0.014 | 0.008 | 0.014 | Integrin alphaLbeta2 antagonist | |||
| 0.019 | 0.013 | 0.021 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET02102 0.021 0.009 DBMET03078 0.019 0.012 DB00129 | DBMET03078 | |
| 0.049 | 0.043 | 0.049 | Cathepsin D inhibitor | |||
| 0.068 | 0.062 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 DBMET02102 0.104 0.028 DBMET03078 0.078 0.052 DBMET00494 0.106 0.026 DB00129 | DB00129 | |
| 0.029 | 0.023 | 0.043 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 DBMET02102 0.043 0.011 DBMET03078 0.027 0.026 DBMET00494 | DBMET03078 | |
| 0.016 | 0.01 | 0.022 | Dipeptidyl peptidase VIII inhibitor | 0.018 0.008 DBMET02102 0.022 0.006 DB00129 | DB00129 | |
| 0.052 | 0.046 | 0.052 | Cathepsin B inhibitor | |||
| 0.042 | 0.037 | 0.095 | Plasmin inhibitor | 0.054 0.03 DBMET00494 0.095 0.019 DB00129 | DB00129 | |
| 0.037 | 0.031 | 0.082 | GABA uptake inhibitor | 0.058 0.011 DBMET02102 0.073 0.006 DBMET03078 0.082 0.005 DBMET00494 0.058 0.011 DB00129 | DBMET00494 | |
| 0.032 | 0.027 | 0.033 | Calpain 1 inhibitor | 0.033 0.025 DBMET03078 | DBMET03078 | |
| 0.012 | 0.008 | 0.012 | Protease activated receptor 1 agonist | 0.011 0.009 DB00129 | ||
| 0.046 | 0.042 | 0.056 | Cytokine production stimulant | 0.048 0.033 DBMET03078 0.056 0.018 DB00129 | DB00129 | |
| 0.051 | 0.047 | 0.07 | DNA helicase inhibitor | 0.053 0.04 DBMET02102 0.07 0.017 DBMET03078 | DBMET03078 | |
| 0.027 | 0.023 | 0.027 | Glucagon receptor antagonist | |||
| 0.029 | 0.025 | 0.049 | Caspase 6 inhibitor | 0.034 0.014 DBMET02102 0.049 0.005 DBMET03078 | DBMET03078 | |
| 0.051 | 0.047 | 0.087 | Thromboxane synthase inhibitor | 0.08 0.012 DBMET02102 0.087 0.009 DBMET03078 0.052 0.042 DB00129 | DBMET03078 | |
| 0.097 | 0.094 | 0.138 | Acetylcholine muscarinic antagonist | 0.11 0.078 DBMET03079 0.138 0.052 DBMET00494 0.122 0.065 DB00129 | DBMET00494 | |
| 0.011 | 0.008 | 0.011 | Neurokinin 3 agonist | 0.01 0.009 DBMET02102 | ||
| 0.097 | 0.095 | 0.132 | Acetylcholine release stimulant | 0.132 0.032 DBMET03078 0.13 0.034 DBMET03079 0.099 0.091 DBMET00494 | DBMET03078 | |
| 0.006 | 0.005 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET02102 0.008 0.004 DBMET03078 0.008 0.004 DBMET00494 0.007 0.004 DB00129 | DBMET00494 | |
| 0.023 | 0.022 | 0.139 | Kynurenine 3 monooxygenase inhibitor | 0.057 0.005 DBMET02102 0.139 0.003 DBMET03078 | DBMET03078 | |
| 0.073 | 0.071 | 0.093 | Opioid kappa receptor antagonist | 0.089 0.047 DBMET00494 0.093 0.043 DB00129 | DB00129 | |
| 0.024 | 0.023 | 0.039 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.013 DBMET02102 0.039 0.013 DBMET03078 0.03 0.018 DB00129 | DBMET03078 | |
| 0.009 | 0.008 | 0.015 | Integrin alphaVbeta5 antagonist | 0.015 0.005 DBMET02102 0.011 0.006 DBMET03078 0.009 0.008 DBMET00494 0.015 0.005 DB00129 | DB00129 | |
| 0.031 | 0.03 | 0.035 | Angiotensin II receptor antagonist | 0.034 0.024 DBMET02102 0.035 0.022 DBMET00494 0.032 0.027 DB00129 | DBMET00494 | |
| 0.02 | 0.02 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.013 DBMET00494 | DBMET00494 | |
| 0.02 | 0.021 | 0.074 | Somatostatin 4 antagonist | 0.074 0.006 DB00129 | DB00129 | |
| 0.038 | 0.038 | 0.043 | Angiotensin AT1 receptor antagonist | 0.042 0.029 DBMET02102 0.043 0.027 DBMET00494 0.038 0.037 DB00129 | DBMET00494 | |
| 0.03 | 0.03 | 0.053 | Glutamate (mGluR group II) agonist | 0.053 0.014 DBMET02102 0.033 0.026 DBMET00494 0.039 0.021 DB00129 | DBMET02102 | |
| 0.002 | 0.003 | 0.004 | Bradykinin B1 receptor agonist | 0.004 0.002 DB00129 | DB00129 | |
| 0.048 | 0.05 | 0.062 | Heparanase inhibitor | 0.062 0.02 DBMET03078 | DBMET03078 | |
| 0.077 | 0.079 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 DBMET02102 0.095 0.037 DBMET03078 0.08 0.07 DB00129 | DBMET03078 | |
| 0.041 | 0.042 | 0.057 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET02102 0.057 0.025 DBMET00494 | DBMET00494 | |
| 0.053 | 0.055 | 0.119 | Purinergic P2X1 antagonist | 0.088 0.021 DBMET02102 0.119 0.012 DBMET03078 0.056 0.05 DBMET03079 0.059 0.045 DBMET00494 0.054 0.053 DB00129 | DBMET03078 | |
| 0.014 | 0.016 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET02102 0.018 0.009 DBMET03078 | DBMET02102 | |
| 0.031 | 0.034 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.016 DB00129 | DB00129 | |
| 0.021 | 0.024 | 0.024 | Melanocortin 3 antagonist | 0.024 0.023 DB00129 | DB00129 | |
| 0.013 | 0.017 | 0.036 | Thromboxane A2 agonist | 0.025 0.004 DBMET02102 0.036 0.003 DBMET03078 0.015 0.011 DB00129 | DBMET03078 | |
| 0.121 | 0.125 | 0.213 | GABA C receptor rho-2 antagonist | 0.148 0.076 DBMET02102 0.187 0.037 DBMET03078 0.213 0.023 DBMET03079 0.21 0.024 DBMET00494 0.155 0.067 DB00129 | DBMET03079 | |
| 0.047 | 0.051 | 0.087 | Leukotriene B4 antagonist | 0.056 0.032 DBMET02102 0.087 0.013 DBMET03078 | DBMET03078 | |
| 0.016 | 0.021 | 0.019 | Nociceptin (N/OFQ) receptor agonist | 0.019 0.017 DB00129 | DB00129 | |
| 0.012 | 0.017 | 0.02 | Integrin beta6 antagonist | 0.016 0.006 DBMET02102 0.02 0.004 DBMET03078 | DBMET03078 | |
| 0.031 | 0.037 | 0.099 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.021 DBMET02102 0.099 0.001 DBMET03078 | DBMET03078 | |
| 0.034 | 0.04 | 0.038 | Aggrecanase 1 inhibitor | 0.038 0.03 DB00129 | DB00129 | |
| 0.018 | 0.024 | 0.025 | Toll-Like receptor 8 agonist | 0.025 0.007 DB00129 | DB00129 | |
| 0.021 | 0.028 | 0.045 | Uridine phosphorylase inhibitor | 0.032 0.016 DBMET02102 0.045 0.01 DBMET03078 | DBMET03078 | |
| 0.032 | 0.039 | 0.252 | Oxytocin antagonist | 0.252 0.004 DBMET03079 | DBMET03079 | |
| 0.039 | 0.046 | 0.05 | Histamine H1 receptor agonist | 0.041 0.037 DBMET03079 0.05 0.019 DB00129 | DB00129 | |
| 0.01 | 0.017 | 0.028 | Integrin alpha4beta1 antagonist | 0.028 0.007 DBMET02102 | DBMET02102 | |
| 0.045 | 0.053 | 0.088 | Plasminogen activator inhibitor | 0.066 0.035 DBMET02102 0.083 0.024 DBMET00494 0.088 0.021 DB00129 | DB00129 | |
| 0.068 | 0.077 | 0.108 | Sphingosine 1-phosphate receptor antagonist | 0.088 0.032 DBMET02102 0.108 0.017 DBMET03078 0.075 0.057 DBMET00494 | DBMET03078 | |
| 0.047 | 0.057 | 0.132 | Sphingosine 1-phosphate receptor 5 agonist | 0.119 0.006 DBMET02102 0.132 0.005 DBMET03078 0.059 0.026 DB00129 | DBMET03078 | |
| 0.057 | 0.066 | 0.084 | Carbonic anhydrase VA inhibitor | 0.062 0.057 DBMET02102 0.084 0.034 DBMET03078 0.075 0.041 DB00129 | DBMET03078 | |
| 0.087 | 0.097 | 0.164 | Anesthetic local | 0.164 0.043 DBMET00494 0.144 0.052 DB00129 | DBMET00494 | |
| 0.028 | 0.038 | 0.083 | RNA-directed RNA polymerase inhibitor | 0.083 0.006 DBMET03078 0.039 0.019 DBMET00494 | DBMET03078 | |
| 0.122 | 0.132 | 0.183 | Nitric oxide antagonist | 0.183 0.075 DBMET03078 | DBMET03078 | |
| 0.075 | 0.086 | 0.082 | CC chemokine 5 receptor agonist | 0.08 0.063 DBMET03079 0.082 0.059 DBMET00494 | DBMET00494 | |
| 0.102 | 0.113 | 0.114 | Alkaline phosphatase inhibitor | 0.114 0.093 DBMET02102 | DBMET02102 | |
| 0.022 | 0.033 | 0.026 | Complement factor 1s inhibitor | 0.026 0.016 DBMET02102 | DBMET02102 | |
| 0.034 | 0.045 | 0.04 | Opioid kappa receptor agonist | 0.04 0.034 DB00129 | DB00129 | |
| 0.029 | 0.041 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 DBMET00494 | DBMET00494 | |
| 0.051 | 0.062 | 0.092 | Leukotriene C antagonist | 0.064 0.021 DBMET02102 0.092 0.005 DBMET03078 | DBMET03078 | |
| 0.046 | 0.058 | 0.073 | Sphingosine kinase 2 inhibitor | 0.056 0.037 DBMET02102 0.073 0.019 DBMET00494 0.052 0.043 DB00129 | DBMET00494 | |
| 0.041 | 0.053 | 0.047 | Diacylglycerol O-acyltransferase inhibitor | 0.047 0.04 DBMET02102 0.047 0.04 DBMET03078 | DBMET03078 | |
| 0.033 | 0.045 | 0.052 | Urokinase inhibitor | 0.052 0.032 DB00129 | DB00129 | |
| 0.029 | 0.041 | 0.052 | Tryptase inhibitor | 0.045 0.016 DBMET00494 0.052 0.011 DB00129 | DB00129 | |
| 0.017 | 0.03 | 0.035 | Methionyl aminopeptidase 2 inhibitor | 0.035 0.011 DBMET00494 | DBMET00494 | |
| 0.041 | 0.053 | 0.063 | Baculoviral IAP repeat-containing protein inhibitor | 0.063 0.005 DBMET00494 | DBMET00494 | |
| 0.019 | 0.032 | 0.04 | Bradykinin B2 receptor antagonist | 0.04 0.015 DB00129 | DB00129 | |
| 0.088 | 0.101 | 0.132 | Protein kinase C gamma inhibitor | 0.097 0.083 DBMET02102 0.132 0.044 DBMET00494 0.116 0.056 DB00129 | DBMET00494 | |
| 0.034 | 0.048 | 0.039 | Plasmepsin II inhibitor | 0.039 0.033 DB00129 | DB00129 | |
| 0.044 | 0.06 | 0.056 | Cathepsin L inhibitor | 0.056 0.043 DB00129 | DB00129 | |
| 0.025 | 0.042 | 0.078 | Phosphoglycerate kinase inhibitor | 0.043 0.018 DBMET02102 0.078 0.009 DBMET03078 0.057 0.012 DB00129 | DBMET03078 | |
| 0.055 | 0.072 | 0.123 | Elastase 1 inhibitor | 0.067 0.051 DBMET02102 0.123 0.011 DBMET03078 | DBMET03078 | |
| 0.055 | 0.072 | 0.068 | Potassium channel large-conductance Ca-activated activator | 0.068 0.047 DBMET02102 0.064 0.052 DBMET00494 | DBMET02102 | |
| 0.013 | 0.03 | 0.042 | Somatostatin 3 antagonist | 0.042 0.008 DB00129 | DB00129 | |
| 0.012 | 0.03 | 0.024 | Vitamin D receptor agonist | 0.024 0.005 DBMET03078 | DBMET03078 | |
| 0.069 | 0.088 | 0.112 | MAP kinase kinase 7 inhibitor | 0.086 0.033 DBMET02102 0.081 0.042 DBMET03078 0.082 0.04 DBMET03079 0.112 0.006 DBMET00494 0.086 0.031 DB00129 | DBMET00494 | |
| 0.05 | 0.07 | 0.068 | Lipocortins synthesis agonist | 0.06 0.035 DBMET02102 0.068 0.023 DBMET03078 0.055 0.047 DB00129 | DBMET03078 | |
| 0.038 | 0.058 | 0.076 | Carbonic anhydrase VB inhibitor | 0.051 0.043 DBMET02102 0.076 0.024 DBMET03078 0.061 0.034 DB00129 | DBMET03078 | |
| 0.049 | 0.07 | 0.081 | Carbonic anhydrase V inhibitor | 0.081 0.035 DBMET03078 0.068 0.044 DB00129 | DBMET03078 | |
| 0.013 | 0.034 | 0.048 | Purinergic P2Y12 antagonist | 0.048 0.007 DBMET02102 0.044 0.008 DBMET03078 | DBMET02102 | |
| 0.036 | 0.057 | 0.05 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 DBMET03078 0.05 0.033 DB00129 | DB00129 | |
| 0.056 | 0.077 | 0.087 | Prolactin release inhibitor | 0.087 0.008 DBMET00494 0.065 0.035 DB00129 | DBMET00494 | |
| 0.055 | 0.076 | 0.18 | Carbonic anhydrase XIII inhibitor | 0.074 0.054 DBMET02102 0.18 0.017 DBMET03078 0.078 0.051 DB00129 | DBMET03078 | |
| 0.076 | 0.098 | 0.099 | Protein kinase C zeta inhibitor | 0.09 0.065 DBMET00494 0.099 0.052 DB00129 | DB00129 | |
| 0.016 | 0.037 | 0.031 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET02102 0.031 0.004 DBMET03078 0.019 0.018 DB00129 | DBMET03078 | |
| 0.005 | 0.027 | 0.033 | Thromboxane agonist | 0.013 0.005 DBMET02102 0.033 0.003 DBMET03078 | DBMET03078 | |
| 0.015 | 0.037 | 0.026 | Lysophosphatidic acid 1 receptor antagonist | 0.026 0.009 DBMET03078 | DBMET03078 | |
| 0.09 | 0.112 | 0.216 | Cholinergic antagonist | 0.129 0.066 DBMET03079 0.216 0.028 DBMET00494 0.118 0.076 DB00129 | DBMET00494 | |
| 0.02 | 0.044 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.019 DBMET00494 | DBMET00494 | |
| 0.021 | 0.045 | 0.03 | Glutamate (mGluR2) antagonist | 0.03 0.02 DBMET00494 | DBMET00494 | |
| 0.074 | 0.098 | 0.195 | Thioredoxin inhibitor | 0.195 0.009 DBMET02102 0.142 0.019 DBMET03078 0.09 0.061 DB00129 | DBMET02102 | |
| 0.025 | 0.05 | 0.044 | Diamine oxidase inhibitor | 0.044 0.019 DB00129 | DB00129 | |
| 0.031 | 0.056 | 0.041 | Thymidine kinase inhibitor | 0.039 0.032 DBMET02102 0.041 0.029 DBMET03078 | DBMET03078 | |
| 0.039 | 0.064 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.02 DBMET00494 | DBMET00494 | |
| 0.087 | 0.112 | 0.212 | Acetylcholine antagonist | 0.126 0.065 DBMET03079 0.212 0.028 DBMET00494 0.113 0.077 DB00129 | DBMET00494 | |
| 0.08 | 0.105 | 0.166 | Carbonic anhydrase XV inhibitor | 0.095 0.074 DBMET02102 0.108 0.058 DBMET03078 0.105 0.061 DBMET00494 0.166 0.026 DB00129 | DB00129 | |
| 0.02 | 0.045 | 0.03 | Glutamate (mGluR2) agonist | 0.03 0.024 DBMET02102 | DBMET02102 | |
| 0.015 | 0.042 | 0.041 | Histone deacetylase 10 inhibitor | 0.041 0.015 DBMET03078 | DBMET03078 | |
| 0.022 | 0.051 | 0.028 | Hedgehog signaling activator | 0.028 0.018 DBMET03078 | DBMET03078 | |
| 0.053 | 0.082 | 0.098 | Protein kinase C beta inhibitor | 0.098 0.014 DBMET00494 0.069 0.05 DB00129 | DBMET00494 | |
| 0.019 | 0.049 | 0.169 | Vasopressin 2 antagonist | 0.169 0.004 DBMET03079 | DBMET03079 | |
| 0.032 | 0.062 | 0.067 | Leukotriene C4 antagonist | 0.041 0.022 DBMET02102 0.067 0.005 DBMET03078 | DBMET03078 | |
| 0.028 | 0.06 | 0.044 | Glycine transporter inhibitor | 0.044 0.036 DB00129 | DB00129 | |
| 0.097 | 0.129 | 0.131 | Antibacterial (Helicobacter pylori) | 0.131 0.067 DBMET02102 0.126 0.073 DBMET03078 0.122 0.078 DB00129 | DBMET02102 | |
| 0.011 | 0.044 | 0.041 | Prostaglandin H2 antagonist | 0.031 0.012 DBMET02102 0.041 0.005 DBMET03078 0.022 0.021 DBMET00494 | DBMET03078 | |
| 0.009 | 0.041 | 0.016 | Thyroid hormone alpha antagonist | 0.016 0.01 DBMET03078 | DBMET03078 | |
| 0.017 | 0.05 | 0.031 | Nicotinic acid receptor 2 antagonist | 0.028 0.015 DBMET03078 0.031 0.011 DBMET00494 | DBMET00494 | |
| 0.012 | 0.045 | 0.02 | Histone deacetylase 3 inhibitor | 0.02 0.019 DBMET03078 | DBMET03078 | |
| 0.024 | 0.058 | 0.045 | Retinoid X alpha receptor antagonist | 0.045 0.009 DBMET03078 | DBMET03078 | |
| 0.018 | 0.053 | 0.12 | Somatostatin agonist | 0.12 0.007 DBMET00494 0.108 0.007 DB00129 | DBMET00494 | |
| 0.039 | 0.075 | 0.217 | CXC chemokine 4 receptor antagonist | 0.169 0.013 DBMET00494 0.217 0.009 DB00129 | DB00129 | |
| 0.216 | 0.253 | 0.349 | Apoptosis agonist | 0.291 0.179 DBMET02102 0.349 0.139 DBMET03078 | DBMET03078 | |
| 0.018 | 0.054 | 0.041 | Histone deacetylase class IV inhibitor | 0.041 0.017 DBMET03078 | DBMET03078 | |
| 0.018 | 0.054 | 0.041 | Histone deacetylase 11 inhibitor | 0.041 0.017 DBMET03078 | DBMET03078 | |
| 0.02 | 0.057 | 0.074 | Retinoid X alpha receptor agonist | 0.038 0.021 DBMET02102 0.074 0.008 DBMET03078 0.039 0.02 DB00129 | DBMET03078 | |
| 0.027 | 0.064 | 0.055 | Retinoid X receptor antagonist | 0.036 0.029 DBMET02102 0.055 0.009 DBMET03078 | DBMET03078 | |
| 0.016 | 0.054 | 0.029 | Dipeptidyl peptidase I inhibitor | 0.029 0.023 DBMET00494 | DBMET00494 | |
| 0.155 | 0.194 | 0.218 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.13 DBMET02102 0.169 0.138 DBMET03078 0.218 0.038 DBMET03079 0.198 0.066 DBMET00494 0.188 0.086 DB00129 | DBMET03079 | |
| 0.019 | 0.059 | 0.042 | Nicotinic acid receptor agonist | 0.042 0.019 DBMET03078 | DBMET03078 | |
| 0.022 | 0.064 | 0.082 | Nicotinic receptor beta4 subunit antagonist | 0.082 0.008 DBMET00494 | DBMET00494 | |
| 0.025 | 0.068 | 0.049 | Protein kinase (CK2) beta inhibitor | 0.032 0.027 DBMET03079 0.049 0.008 DBMET00494 | DBMET00494 | |
| 0.021 | 0.065 | 0.047 | HMG CoA reductase inhibitor | 0.037 0.019 DBMET02102 0.047 0.009 DBMET03078 | DBMET03078 | |
| 0.078 | 0.122 | 0.27 | Cholesterol synthesis inhibitor | 0.129 0.058 DBMET02102 0.27 0.015 DBMET03078 0.121 0.064 DBMET03079 0.106 0.079 DBMET00494 | DBMET03078 | |
| 0.02 | 0.064 | 0.045 | Carnitine palmitoyltransferase inhibitor | 0.045 0.011 DBMET00494 | DBMET00494 | |
| 0.016 | 0.06 | 0.065 | HCV NS5B polymerase inhibitor | 0.065 0.008 DBMET03078 0.032 0.021 DBMET00494 | DBMET03078 | |
| 0.019 | 0.063 | 0.033 | Epoxide hydrolase 1 inhibitor | 0.03 0.022 DBMET03078 0.033 0.018 DBMET00494 | DBMET00494 | |
| 0.039 | 0.085 | 0.072 | Protein kinase C iota inhibitor | 0.072 0.031 DB00129 | DB00129 | |
| 0.031 | 0.077 | 0.128 | Plasminogen activator inhibitor antagonist | 0.079 0.015 DBMET02102 0.128 0.006 DBMET03078 | DBMET03078 | |
| 0.026 | 0.072 | 0.091 | Thromboxane A2 antagonist | 0.059 0.029 DBMET02102 0.091 0.01 DBMET03078 | DBMET03078 | |
| 0.018 | 0.064 | 0.071 | Histone deacetylase 2 inhibitor | 0.071 0.012 DBMET03078 | DBMET03078 | |
| 0.007 | 0.055 | 0.027 | Somatostatin 2 agonist | 0.027 0.005 DBMET00494 0.027 0.005 DB00129 | DB00129 | |
| 0.019 | 0.068 | 0.103 | ATP citrate lysase inhibitor | 0.036 0.016 DBMET02102 0.103 0.003 DBMET03078 | DBMET03078 | |
| 0.04 | 0.09 | 0.061 | Dihydroorotate oxidase inhibitor | 0.058 0.033 DBMET03078 0.061 0.028 DBMET00494 | DBMET00494 | |
| 0.038 | 0.088 | 0.068 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.068 0.032 DBMET03078 | DBMET03078 | |
| 0.025 | 0.075 | 0.077 | Guanylate cyclase inhibitor | 0.045 0.027 DBMET02102 0.077 0.003 DBMET03078 0.061 0.011 DBMET03079 0.067 0.006 DBMET00494 0.05 0.021 DB00129 | DBMET03078 | |
| 0.055 | 0.106 | 0.086 | Peroxisome proliferator-activated receptor gamma antagonist | 0.067 0.063 DBMET02102 0.086 0.027 DBMET03078 | DBMET03078 | |
| 0.021 | 0.075 | 0.057 | Purinergic P2Y antagonist | 0.054 0.023 DBMET02102 0.057 0.021 DBMET03078 | DBMET03078 | |
| 0.016 | 0.07 | 0.064 | 5-Alpha-reductase inhibitor | 0.034 0.029 DBMET02102 0.064 0.015 DBMET03078 | DBMET03078 | |
| 0.014 | 0.07 | 0.07 | Retinoid X receptor agonist | 0.033 0.027 DBMET02102 0.07 0.01 DBMET03078 0.034 0.026 DB00129 | DBMET03078 | |
| 0.012 | 0.068 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.014 DBMET00494 | DBMET00494 | |
| 0.027 | 0.084 | 0.1 | Thromboxane antagonist | 0.059 0.033 DBMET02102 0.1 0.011 DBMET03078 | DBMET03078 | |
| 0.034 | 0.09 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.045 0.043 DBMET02102 0.047 0.038 DBMET03078 0.049 0.033 DB00129 | DB00129 | |
| 0.117 | 0.174 | 0.506 | Lipocortins synthesis antagonist | 0.241 0.037 DBMET02102 0.506 0.004 DBMET03078 0.139 0.123 DBMET00494 | DBMET03078 | |
| 0.009 | 0.066 | 0.02 | Complement factor D inhibitor | 0.017 0.016 DBMET03079 0.02 0.009 DBMET00494 | DBMET00494 | |
| 0.07 | 0.127 | 0.115 | Xanthine oxidase inhibitor | 0.115 0.05 DBMET03078 | DBMET03078 | |
| 0.01 | 0.068 | 0.032 | Sphingosine 1-phosphate receptor 3 agonist | 0.032 0.026 DBMET02102 | DBMET02102 | |
| 0.007 | 0.065 | 0.021 | Angiotensin AT2 receptor antagonist | 0.021 0.015 DBMET00494 | DBMET00494 | |
| 0.027 | 0.085 | 0.376 | Dihydroorotase inhibitor | 0.042 0.035 DBMET03078 0.05 0.025 DBMET03079 0.376 0.002 DBMET00494 | DBMET00494 | |
| 0.028 | 0.088 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.053 0.033 DBMET00494 0.049 0.038 DB00129 | DBMET00494 | |
| 0.039 | 0.099 | 0.104 | Leukotriene antagonist | 0.066 0.044 DBMET02102 0.104 0.02 DBMET03078 | DBMET03078 | |
| 0.019 | 0.079 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET03078 | DBMET03078 | |
| 0.004 | 0.064 | 0.051 | Prostaglandin EP4 agonist | 0.051 0.005 DBMET03078 | DBMET03078 | |
| 0.014 | 0.075 | 0.22 | Antidiuretic hormone antagonist | 0.22 0.005 DBMET03079 | DBMET03079 | |
| 0.042 | 0.103 | 0.07 | Beta adrenoreceptor antagonist | 0.07 0.038 DBMET00494 0.06 0.055 DB00129 | DBMET00494 | |
| 0.007 | 0.069 | 0.021 | Purinergic P2T antagonist | 0.021 0.015 DBMET02102 | DBMET02102 | |
| 0.016 | 0.079 | 0.032 | Retinoid X gamma receptor antagonist | 0.032 0.01 DBMET03078 | DBMET03078 | |
| 0.018 | 0.082 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.021 DBMET03078 | DBMET03078 | |
| 0.098 | 0.162 | 0.183 | Hexokinase inhibitor | 0.183 0.047 DBMET03078 | DBMET03078 | |
| 0.009 | 0.075 | 0.023 | 5-Alpha-reductase 2 inhibitor | 0.023 0.011 DBMET03078 | DBMET03078 | |
| 0.01 | 0.075 | 0.058 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 DBMET02102 0.058 0.005 DBMET03078 | DBMET03078 | |
| 0.01 | 0.077 | 0.051 | Histone deacetylase 5 inhibitor | 0.051 0.016 DBMET03078 | DBMET03078 | |
| 0.018 | 0.085 | 0.045 | Carnitine palmitoyltransferase 1 inhibitor | 0.045 0.011 DBMET00494 | DBMET00494 | |
| 0.179 | 0.249 | 0.347 | Calcium channel activator | 0.245 0.154 DBMET02102 0.295 0.096 DBMET03078 0.304 0.088 DBMET03079 0.347 0.052 DBMET00494 0.264 0.131 DB00129 | DBMET00494 | |
| 0.013 | 0.083 | 0.084 | Prostaglandin D2 agonist | 0.045 0.01 DBMET02102 0.084 0.003 DBMET03078 | DBMET03078 | |
| 0.002 | 0.072 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET03078 | DBMET03078 | |
| 0.033 | 0.104 | 0.059 | Glucose-6-phosphate translocase inhibitor | 0.059 0.025 DBMET03078 | DBMET03078 | |
| 0.036 | 0.107 | 0.092 | Antineoplastic antibiotic | 0.092 0.05 DBMET03079 | DBMET03079 | |
| 0.009 | 0.08 | 0.028 | Retinoid X beta receptor agonist | 0.028 0.009 DBMET03078 | DBMET03078 | |
| 0.009 | 0.081 | 0.031 | Retinoid X gamma receptor agonist | 0.031 0.01 DBMET03078 | DBMET03078 | |
| 0.028 | 0.099 | 0.062 | CC chemokine 4 receptor antagonist | 0.062 0.015 DBMET00494 | DBMET00494 | |
| 0.034 | 0.107 | 0.178 | Peroxisome proliferator-activated receptor gamma agonist | 0.061 0.057 DBMET02102 0.178 0.008 DBMET03078 | DBMET03078 | |
| 0.014 | 0.087 | 0.056 | Free fatty acid receptor 1 antagonist | 0.034 0.024 DBMET02102 0.056 0.006 DBMET03078 0.034 0.024 DBMET03079 0.035 0.022 DBMET00494 | DBMET03078 | |
| 0.018 | 0.091 | 0.079 | Factor XI inhibitor | 0.079 0.005 DBMET03079 0.047 0.011 DBMET00494 | DBMET03079 | |
| 0.012 | 0.087 | 0.116 | Prostaglandin agonist | 0.028 0.025 DBMET02102 0.116 0.005 DBMET03078 | DBMET03078 | |
| 0.047 | 0.123 | 0.903 | HIV-1 integrase inhibitor | 0.903 0.001 DBMET03078 | DBMET03078 | |
| 0.028 | 0.106 | 0.049 | Elastase inhibitor | 0.049 0.044 DBMET03078 | DBMET03078 | |
| 0.024 | 0.103 | 0.052 | Nerve growth factor antagonist | 0.039 0.038 DBMET02102 0.044 0.028 DBMET03078 0.052 0.015 DBMET03079 0.048 0.021 DBMET00494 | DBMET03079 | |
| 0.045 | 0.124 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.066 0.04 DBMET00494 | DBMET00494 | |
| 0.067 | 0.148 | 0.096 | AMP-activated protein kinase stimulant | 0.096 0.075 DBMET02102 0.089 0.088 DBMET00494 | DBMET02102 | |
| 0.045 | 0.126 | 0.266 | Acetylcholine nicotinic antagonist | 0.072 0.066 DBMET03079 0.266 0.008 DBMET00494 0.073 0.064 DB00129 | DBMET00494 | |
| 0.035 | 0.116 | 0.241 | Neuronal nicotinic receptor antagonist | 0.061 0.053 DBMET03079 0.241 0.007 DBMET00494 | DBMET00494 | |
| 0.008 | 0.09 | 0.081 | Vasopressin 1 antagonist | 0.081 0.011 DBMET03079 | DBMET03079 | |
| 0.031 | 0.113 | 0.059 | Topoisomerase II beta inhibitor | 0.059 0.023 DBMET03078 | DBMET03078 | |
| 0.009 | 0.091 | 0.028 | Histone deacetylase 1 inhibitor | 0.028 0.016 DBMET03078 | DBMET03078 | |
| 0.043 | 0.126 | 0.065 | Epoxide hydrolase inhibitor | 0.065 0.06 DBMET03078 | DBMET03078 | |
| 0.062 | 0.145 | 0.15 | Lanosterol 14 alpha demethylase inhibitor | 0.11 0.041 DBMET02102 0.15 0.011 DBMET03078 0.113 0.038 DB00129 | DBMET03078 | |
| 0.044 | 0.127 | 0.07 | Ryanodine receptor antagonist | 0.056 0.051 DBMET02102 0.07 0.018 DBMET03078 0.068 0.021 DBMET00494 | DBMET03078 | |
| 0.007 | 0.091 | 0.044 | Prostaglandin EP2 agonist | 0.044 0.007 DBMET03078 | DBMET03078 | |
| 0.005 | 0.09 | 0.079 | Prostacyclin agonist | 0.02 0.008 DBMET02102 0.079 0.004 DBMET03078 | DBMET03078 | |
| 0.011 | 0.096 | 0.029 | Prostaglandin EP4 antagonist | 0.029 0.016 DBMET03078 | DBMET03078 | |
| 0.047 | 0.133 | 0.111 | Adrenaline agonist | 0.111 0.03 DBMET00494 | DBMET00494 | |
| 0.039 | 0.126 | 0.076 | Pregnane X receptor antagonist | 0.057 0.038 DBMET02102 0.076 0.009 DBMET03078 0.055 0.045 DBMET03079 0.055 0.043 DBMET00494 | DBMET03078 | |
| 0.056 | 0.145 | 0.121 | Caspase 7 inhibitor | 0.121 0.014 DBMET03078 0.081 0.06 DBMET03079 0.076 0.072 DBMET00494 | DBMET03078 | |
| 0.01 | 0.099 | 0.033 | Histone deacetylase class IIa inhibitor | 0.033 0.021 DBMET03078 | DBMET03078 | |
| 0.101 | 0.193 | 0.173 | Tumour necrosis factor antagonist | 0.173 0.073 DBMET00494 | DBMET00494 | |
| 0.106 | 0.198 | 0.313 | Hypolipemic | 0.171 0.118 DBMET02102 0.313 0.045 DBMET03078 | DBMET03078 | |
| 0.11 | 0.204 | 0.164 | ATPase inhibitor | 0.164 0.079 DBMET03078 | DBMET03078 | |
| 0.005 | 0.1 | 0.064 | Prostaglandin E2 agonist | 0.064 0.005 DBMET03078 | DBMET03078 | |
| 0.02 | 0.116 | 0.04 | Retinoic acid alpha receptor agonist | 0.036 0.034 DBMET03078 0.04 0.025 DBMET00494 | DBMET00494 | |
| 0.004 | 0.101 | 0.033 | G-protein-coupled receptor 120 agonist | 0.033 0.005 DBMET03078 | DBMET03078 | |
| 0.006 | 0.105 | 0.075 | Vasopressin 1A antagonist | 0.075 0.008 DBMET03079 | DBMET03079 | |
| 0.011 | 0.111 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.018 DBMET03078 | DBMET03078 | |
| 0.035 | 0.137 | 0.126 | Prostaglandin F2 alpha antagonist | 0.106 0.009 DBMET02102 0.126 0.006 DBMET03078 | DBMET03078 | |
| 0.009 | 0.111 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 DBMET03078 | DBMET03078 | |
| 0.119 | 0.221 | 0.233 | Cyclic AMP phosphodiesterase inhibitor | 0.233 0.073 DBMET03078 | DBMET03078 | |
| 0.011 | 0.115 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | 0.031 0.027 DBMET00494 | DBMET00494 | |
| 0.024 | 0.129 | 0.059 | Acetylcholine M3 receptor antagonist | 0.059 0.042 DBMET00494 | DBMET00494 | |
| 0.007 | 0.114 | 0.051 | Squalene synthetase inhibitor | 0.051 0.014 DBMET03078 | DBMET03078 | |
| 0.033 | 0.142 | 0.054 | Factor III inhibitor | 0.054 0.026 DBMET03078 0.052 0.03 DBMET00494 | DBMET03078 | |
| 0.004 | 0.118 | 0.068 | Free fatty acid receptor 1 agonist | 0.018 0.012 DBMET02102 0.068 0.004 DBMET03078 | DBMET03078 | |
| 0.017 | 0.132 | 0.058 | Factor XIa inhibitor | 0.058 0.013 DBMET00494 | DBMET00494 | |
| 0.018 | 0.134 | 0.04 | Fructose-1,6-bisphosphatase inhibitor | 0.04 0.039 DBMET03078 | DBMET03078 | |
| 0.025 | 0.143 | 0.059 | 5 Hydroxytryptamine 2A agonist | 0.057 0.05 DBMET00494 0.059 0.048 DB00129 | DB00129 | |
| 0.014 | 0.134 | 0.078 | Peroxisome proliferator-activated receptor alpha agonist | 0.078 0.018 DBMET03078 | DBMET03078 | |
| 0.097 | 0.22 | 0.139 | CF transmembrane conductance regulator agonist | 0.133 0.111 DBMET02102 0.139 0.098 DBMET03078 0.134 0.108 DBMET03079 | DBMET03078 | |
| 0.103 | 0.228 | 0.215 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.215 0.08 DB00129 | DB00129 | |
| 0.021 | 0.147 | 0.093 | Phenylethanolamine N methyltransferase inhibitor | 0.093 0.003 DBMET00494 | DBMET00494 | |
| 0.028 | 0.155 | 0.746 | HIV-1 integrase (3'-Processing) inhibitor | 0.746 0.002 DBMET03078 | DBMET03078 | |
| 0.02 | 0.151 | 0.038 | ADAM10 endopeptidase inhibitor | 0.038 0.017 DBMET00494 | DBMET00494 | |
| 0.019 | 0.151 | 0.073 | Somatostatin 4 agonist | 0.073 0.009 DBMET00494 0.037 0.025 DB00129 | DBMET00494 | |
| 0.03 | 0.164 | 0.047 | Heme oxygenase inhibitor | 0.047 0.019 DBMET03078 | DBMET03078 | |
| 0.009 | 0.148 | 0.047 | Peroxisome proliferator-activated receptor delta agonist | 0.047 0.014 DBMET03078 | DBMET03078 | |
| 0.022 | 0.163 | 0.132 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.036 DBMET03079 0.132 0.008 DBMET00494 | DBMET00494 | |
| 0.019 | 0.162 | 0.06 | Acetylcholine M5 receptor antagonist | 0.06 0.042 DBMET00494 | DBMET00494 | |
| 0.176 | 0.321 | 0.544 | Calcium channel L-type activator | 0.372 0.101 DBMET03079 0.544 0.014 DBMET00494 | DBMET00494 | |
| 0.045 | 0.192 | 0.1 | Gastric antisecretory | 0.1 0.066 DBMET03078 | DBMET03078 | |
| 0.016 | 0.164 | 0.074 | Aldose reductase inhibitor | 0.074 0.025 DBMET03078 | DBMET03078 | |
| 0.03 | 0.18 | 0.072 | Glucosylceramidase inhibitor | 0.072 0.021 DBMET00494 | DBMET00494 | |
| 0.004 | 0.154 | 0.072 | Prostaglandin D2 antagonist | 0.072 0.005 DBMET03078 | DBMET03078 | |
| 0.004 | 0.156 | 0.037 | Growth hormone secretagogue receptor agonist | 0.037 0.023 DBMET00494 | DBMET00494 | |
| 0.035 | 0.188 | 0.076 | CDC25A inhibitor | 0.076 0.048 DBMET03078 | DBMET03078 | |
| 0.022 | 0.175 | 0.039 | Vanilloid 3 antagonist | 0.039 0.024 DBMET03078 | DBMET03078 | |
| 0.03 | 0.184 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 DBMET03078 | DBMET03078 | |
| 0.014 | 0.171 | 0.174 | Prostaglandin EP2 antagonist | 0.073 0.031 DBMET02102 0.174 0.008 DBMET03078 | DBMET03078 | |
| 0.028 | 0.187 | 0.138 | Nicotinic alpha3beta2 receptor antagonist | 0.07 0.018 DBMET03079 0.138 0.004 DBMET00494 | DBMET00494 | |
| 0.01 | 0.171 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.017 DBMET00494 | DBMET00494 | |
| 0.074 | 0.236 | 0.181 | Farnesoid X receptor antagonist | 0.181 0.029 DBMET03078 | DBMET03078 | |
| 0.046 | 0.21 | 0.113 | 5 Hydroxytryptamine 3A agonist | 0.113 0.062 DBMET03079 0.096 0.08 DBMET00494 0.111 0.064 DB00129 | DBMET03079 | |
| 0.028 | 0.192 | 0.064 | Transcription factor AP-1 inhibitor | 0.064 0.039 DBMET03078 | DBMET03078 | |
| 0.049 | 0.217 | 0.123 | Nav1.3 sodium channel blocker | 0.123 0.07 DBMET00494 | DBMET00494 | |
| 0.032 | 0.2 | 0.098 | Protein kinase A inhibitor | 0.098 0.047 DB00129 | DB00129 | |
| 0.012 | 0.181 | 0.045 | Peroxisome proliferator-activated receptor delta antagonist | 0.045 0.011 DBMET03078 | DBMET03078 | |
| 0.135 | 0.304 | 0.236 | Toll-Like receptor agonist | 0.236 0.162 DBMET02102 | DBMET02102 | |
| 0.008 | 0.18 | 0.034 | Farnesoid X receptor agonist | 0.034 0.031 DBMET03078 | DBMET03078 | |
| 0.033 | 0.208 | 0.147 | Protein kinase B gamma inhibitor | 0.147 0.017 DB00129 | DB00129 | |
| 0.006 | 0.182 | 0.033 | Leukotriene D4 antagonist | 0.033 0.014 DBMET03078 | DBMET03078 | |
| 0.022 | 0.201 | 0.078 | Androgen agonist | 0.06 0.042 DBMET03078 0.078 0.025 DBMET00494 | DBMET00494 | |
| 0.056 | 0.24 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.072 DBMET03078 | DBMET03078 | |
| 0.007 | 0.192 | 0.047 | Urate transporter 1 inhibitor | 0.047 0.02 DBMET03078 | DBMET03078 | |
| 0.025 | 0.21 | 0.059 | CDC25B inhibitor | 0.059 0.052 DBMET03078 | DBMET03078 | |
| 0.047 | 0.241 | 0.095 | mTOR complex 2 inhibitor | 0.087 0.053 DBMET03079 0.095 0.039 DBMET00494 | DBMET00494 | |
| 0.015 | 0.211 | 0.801 | HIV-1 integrase (Strand Transfer) inhibitor | 0.801 0.001 DBMET03078 | DBMET03078 | |
| 0.006 | 0.21 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.037 0.012 DBMET03079 0.045 0.007 DBMET00494 | DBMET00494 | |
| 0.007 | 0.214 | 0.034 | Motilin receptor agonist | 0.034 0.008 DBMET00494 | DBMET00494 | |
| 0.058 | 0.266 | 0.144 | Interleukin 4 antagonist | 0.144 0.055 DBMET03078 | DBMET03078 | |
| 0.005 | 0.216 | 0.05 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 DBMET03079 0.05 0.004 DBMET00494 | DBMET00494 | |
| 0.169 | 0.382 | 0.407 | Antiinflammatory | 0.407 0.135 DBMET02102 | DBMET02102 | |
| 0.03 | 0.248 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.048 DBMET03079 0.073 0.052 DBMET00494 | DBMET03079 | |
| 0.128 | 0.355 | 0.577 | Analgesic | 0.577 0.031 DBMET00494 | DBMET00494 | |
| 0.004 | 0.232 | 0.026 | Nicotinic alpha4 receptor agonist | 0.016 0.012 DBMET03079 0.026 0.005 DBMET00494 | DBMET00494 | |
| 0.028 | 0.258 | 0.084 | Macrophage migration inhibitory factor inhibitor | 0.084 0.047 DBMET03078 | DBMET03078 | |
| 0.02 | 0.253 | 0.052 | DNA gyrase subunit A inhibitor | 0.052 0.015 DBMET00494 | DBMET00494 | |
| 0.015 | 0.254 | 0.069 | Dopamine uptake inhibitor | 0.069 0.031 DBMET00494 | DBMET00494 | |
| 0.017 | 0.26 | 0.158 | Nicotinic alpha4beta2 receptor antagonist | 0.111 0.023 DBMET03079 0.158 0.007 DBMET00494 | DBMET00494 | |
| 0.008 | 0.256 | 0.021 | Somatostatin 3 agonist | 0.021 0.009 DBMET00494 | DBMET00494 | |
| 0.004 | 0.254 | 0.041 | Prostaglandin EP3 antagonist | 0.041 0.013 DBMET03078 | DBMET03078 | |
| 0.008 | 0.259 | 0.033 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.033 0.004 DBMET00494 | DBMET00494 | |
| 0.109 | 0.364 | 0.201 | Toll-Like receptor 7 agonist | 0.201 0.199 DBMET02102 | DBMET02102 | |
| 0.007 | 0.268 | 0.031 | 5 Hydroxytryptamine 6 agonist | 0.031 0.015 DBMET00494 | DBMET00494 | |
| 0.017 | 0.281 | 0.164 | Leukotriene synthesis inhibitor | 0.164 0.008 DBMET03078 | DBMET03078 | |
| 0.015 | 0.282 | 0.067 | Amidase inhibitor | 0.067 0.053 DBMET03078 | DBMET03078 | |
| 0.079 | 0.347 | 0.242 | Lipoxygenase inhibitor | 0.242 0.105 DBMET03078 | DBMET03078 | |
| 0.021 | 0.302 | 0.06 | 5 Hydroxytryptamine 3 agonist | 0.06 0.048 DBMET00494 | DBMET00494 | |
| 0.082 | 0.369 | 0.158 | Death-associated protein kinase 2 inhibitor | 0.158 0.089 DB00129 | DB00129 | |
| 0.009 | 0.298 | 0.189 | Prostaglandin antagonist | 0.189 0.007 DBMET03078 | DBMET03078 | |
| 0.01 | 0.318 | 0.064 | Dihydroorotate dehydrogenase inhibitor | 0.064 0.025 DBMET00494 | DBMET00494 | |
| 0.06 | 0.378 | 0.14 | Pregnane X receptor agonist | 0.14 0.073 DBMET03078 | DBMET03078 | |
| 0.062 | 0.384 | 0.245 | 5 Hydroxytryptamine 1E antagonist | 0.245 0.08 DBMET03079 0.24 0.086 DBMET00494 | DBMET03079 | |
| 0.037 | 0.378 | 0.078 | Interleukin 5 antagonist | 0.078 0.077 DBMET03078 | DBMET03078 | |
| 0.009 | 0.364 | 0.056 | Cyclin-dependent kinase 6 inhibitor | 0.056 0.045 DBMET00494 | DBMET00494 | |
| 0.004 | 0.361 | 0.059 | Oleamide hydrolase inhibitor | 0.059 0.021 DBMET03078 | DBMET03078 | |
| 0.004 | 0.361 | 0.037 | Acetylcholine M1 receptor agonist | 0.037 0.036 DBMET00494 | DBMET00494 | |
| 0.014 | 0.375 | 0.086 | Acetylcholine M4 receptor antagonist | 0.086 0.04 DBMET00494 | DBMET00494 | |
| 0.026 | 0.389 | 0.092 | Uric acid excretion stimulant | 0.092 0.062 DBMET03078 | DBMET03078 | |
| 0.012 | 0.379 | 0.135 | Acetylcholine nicotinic agonist | 0.135 0.021 DBMET00494 | DBMET00494 | |
| 0.006 | 0.382 | 0.058 | Acetylcholine muscarinic agonist | 0.058 0.035 DBMET00494 | DBMET00494 | |
| 0.055 | 0.435 | 0.199 | 12-Lipoxygenase inhibitor | 0.199 0.153 DBMET03078 | DBMET03078 | |
| 0.017 | 0.418 | 0.14 | Protein kinase C delta inhibitor | 0.14 0.026 DBMET03079 0.088 0.066 DBMET00494 | DBMET03079 | |
| 0.012 | 0.435 | 0.123 | Acetylcholine agonist | 0.123 0.035 DBMET00494 | DBMET00494 | |
| 0.012 | 0.439 | 0.094 | 5-Lipoxygenase inhibitor | 0.094 0.068 DBMET03078 | DBMET03078 | |
| 0.029 | 0.481 | 0.153 | Electron transport complex I inhibitor | 0.153 0.019 DBMET03078 | DBMET03078 | |
| 0.006 | 0.461 | 0.049 | Nicotinic neuronal receptor agonist | 0.049 0.047 DBMET00494 | DBMET00494 | |
| 0.019 | 0.494 | 0.086 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.086 0.055 DB00129 | DB00129 | |
| 0.003 | 0.481 | 0.01 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.01 0.005 DBMET00494 | DBMET00494 | |
| 0.008 | 0.49 | 0.066 | CXC chemokine receptor antagonist | 0.066 0.056 DB00129 | DB00129 | |
| 0.043 | 0.547 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | 0.226 0.123 DBMET03078 | DBMET03078 | |
| 0.045 | 0.55 | 0.332 | Antiobesity | 0.332 0.096 DBMET00494 | DBMET00494 | |
| 0.009 | 0.554 | 0.078 | Myc inhibitor | 0.078 0.014 DBMET00494 | DBMET00494 | |
| 0.015 | 0.561 | 0.043 | Glucose-6-phosphate dehydrogenase inhibitor | 0.043 0.018 DBMET00494 | DBMET00494 | |
| 0.026 | 0.575 | 0.065 | Heme oxygenase stimulant | 0.065 0.033 DBMET00494 | DBMET00494 | |
| 0.006 | 0.567 | 0.105 | Check point kinase 2 inhibitor | 0.105 0.061 DBMET00494 | DBMET00494 | |
| 0.047 | 0.679 | 0.213 | Caspase 3 stimulant | 0.213 0.151 DBMET03078 | DBMET03078 | |
| 0.014 | 0.66 | 0.064 | CC chemokine receptor 2B antagonist | 0.064 0.015 DBMET00494 | DBMET00494 | |
| 0.067 | 0.716 | 0.121 | CC chemokine 6 receptor antagonist | 0.121 0.111 DBMET00494 | DBMET00494 | |
| 0.005 | 0.675 | 0.058 | Dopamine transporter inhibitor | 0.058 0.026 DBMET00494 | DBMET00494 | |
| 0.004 | 0.676 | 0.102 | Nicotinic receptor alpha4 subunit antagonist | 0.102 0.008 DBMET00494 | DBMET00494 | |
| 0.008 | 0.737 | 0.095 | MAP-kinase-activated kinase 2 inhibitor | 0.095 0.031 DBMET00494 | DBMET00494 | |
| 0.009 | 0.741 | 0.103 | MAP-kinase-activated kinase inhibitor | 0.103 0.036 DBMET00494 | DBMET00494 | |
| 0.034 | 0.784 | 0.137 | MAP kinase kinase 4 inhibitor | 0.137 0.094 DBMET00494 | DBMET00494 | |
| 0.003 | 0.77 | 0.049 | 5 Hydroxytryptamine 2C agonist | 0.049 0.028 DBMET00494 | DBMET00494 | |
| 0.004 | 0.777 | 0.15 | Acetylcholine M2 receptor agonist | 0.15 0.004 DBMET03079 | DBMET03079 | |
| 0.011 | 0.793 | 0.263 | Acetylcholine M3 receptor agonist | 0.263 0.003 DBMET03079 0.092 0.05 DBMET00494 | DBMET03079 | |
| 0.005 | 0.827 | 0.399 | HIV-1 reverse transcriptase inhibitor | 0.399 0.004 DBMET03078 | DBMET03078 | |
| 0.056 | 0.885 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.179 DBMET00494 | DBMET00494 | |
| 0.003 | 0.854 | 0.087 | Phosphodiesterase 2A inhibitor | 0.087 0.011 DBMET03079 | DBMET03079 | |
| 0.003 | 0.861 | 0.097 | Phosphodiesterase II inhibitor | 0.097 0.012 DBMET03079 | DBMET03079 | |
| 0.005 | 0.891 | 0.248 | DNA directed RNA polymerase inhibitor | 0.248 0.009 DBMET03078 | DBMET03078 | |
| 0.012 | 0.912 | 0.12 | MAP3K9 inhibitor | 0.12 0.113 DBMET00494 | DBMET00494 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |